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Body of Abstract  
 
Background: Post-stroke dysphagia and post-stroke depression (PSD) can have 
devastating effects on stroke survivors and substantial financial impacts on the 
healthcare system; however, there is a dearth of research examining this patient 
population. Thus, we studied the incidence, risk, and cost of PSD in patients with post-
stroke dysphagia.  
Methods: We conducted a retrospective, cross-sectional study of individuals with a 
primary diagnosis of acute ischemic stroke and secondary diagnoses of dysphagia and/or 
depression using administrative claims data from the 2017 Medicare 5% Limited Data 
Set. Additionally, we developed a novel dysphagia severity index for use with 
administrative data and applied it to our data sets. 
Results: Persons with post-stroke dysphagia were as, or slightly more, likely to have PSD 
compared to the general stroke population. Those with dysphagia (irrespective of 
severity) had greater odds and hazard of diagnosis of PSD in the 90 days after discharge, 
and those with dysphagia and PSD incurred higher healthcare costs.  
Conclusion: Our results supported an association between post-stroke dysphagia and PSD 
and that the presence of PSD in patients with post-stroke dysphagia increased post-
discharge cost. Thus, future research is warranted to further explore the effects of PSD 
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Background and Significance 
Stroke 
Stroke is one of the leading causes of morbidity, mortality, and long-term disability 
worldwide, impacting more than 795,000 people per year in the United States, with 
approximately 75% of strokes occurring in people over the age of 65 (Centers for Disease 
Control, 2020). Many stroke survivors experience serious physical and psychological 
consequences after stroke, such as dysphagia (difficulty swallowing) and depression 
(Kumar et al., 2010; National Stroke Association, n.d.). These common stroke sequelae 
often delay functional recovery and are associated with poor patient outcomes, 




Dysphagia is a significant impairment that can occur in up to 78% of stroke survivors 
(Martino et al., 2005). This condition has many negative consequences, including 
increased burden on caregivers and healthcare providers, increased healthcare costs due 
to prolonged hospitalizations and readmissions, institutionalization after discharge, 
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decreased quality of life (QOL), and increased mortality (Altman et al., 2010; National 
Stroke Association, n.d.). Many dysphagic patients experience improvement in swallow 
function within the first two to four weeks after stroke (Bahcecı et al., 2017); however, 
some patients continue with persistent dysphagia resulting in long-lasting disability 
(Kumar et al., 2010). Dysphagia is also associated with serious complications and 
comorbidities, such as malnutrition, dehydration, aspiration pneumonia, compromised 
overall health (American Speech-Language-Hearing Association [ASHA], n.d.) and 
depressive symptoms (Dziewas, et al., 2017; Holland, 2011; Verdonschot et al., 2013, 
2017). Furthermore, dysphagia has serious psychosocial impacts, with dysphagic patients 
reporting disinterest in eating, embarrassment, reduced self-esteem, and social isolation 
(ASHA, n.d.; Ekberg et al., 2002). 
 
Post-Stroke Depression 
Post-stroke depression (PSD) is the most common stroke-related neuropsychiatric 
disorder, affecting approximately one-third of stroke survivors (Hackett & Pickles, 2014; 
Towfighi et al., 2017). PSD is a major predictor of negative outcomes after stroke due to 
its association with cognitive and social impairments, reduced treatment efficacy, 
disability, poor functional and rehabilitative outcomes, poor QOL, and high mortality 
(Bucur & Papagno, 2018; Bhogal et al., 2004; Cole et al., 2001; Das & Rajanikant, 2018; 
Towfighi et al., 2017). Though a large number of risk factors for PSD have been 
investigated, such as demographics (e.g., age, gender, race), social factors (e.g., marital 
status, social support), and medical history (e.g., history of stroke, premorbid 
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cardiovascular risk factors, biomarkers), results from the literature remain controversial 
(Babkair, 2017). Despite the substantial prevalence and serious consequences of PSD, it 
remains under-recognized and, therefore, underidentified by healthcare providers 
(Ibrahimagic et al., 2019; Kumar et al., 2010). 
 
Problem Statement   
It is known that both post-stroke dysphagia and PSD can have devastating effects on 
patients’ physical, psychological, and social well-being as well as substantial financial 
impacts on patients, caregivers, and the healthcare system (Dziewas et al., 2017; Paolucci 
et al., 2019); however, because of the dearth of research specifically examining PSD in 
post-stroke dysphagic patients, the degree to which these condition are associated, how 
they impact stroke survivors, and their combined effects of post-stroke recovery are not 
known. Furthermore, there is a lack of clinical guidelines to direct clinical practice and 
treatment in this patient population. For these reasons, there is a great need for research 
to examine the role of PSD in patients with post-stroke dysphagia. Thus, this study will 
provide essential information about the association between PSD and post-stroke 
dysphagia and propose a novel methodology for classifying dysphagia severity for use in  
administrative data research, which may lead to future studies to examine the influence 
of PSD on post-stroke dysphagia recovery, establish protocols for early identification of 
post-stoke dysphagic patients with PSD,  and develop treatment strategies to address 





1. What is the rate of PSD in patients with post-stroke dysphagia? 
2. How can dysphagia severity in a post-stroke population be categorized using 
dysphagia-specific ICD-10 diagnosis and procedure codes to determine if dysphagia 
severity impacts diagnosis of PSD?  






CHAPTER 2: REVIEW OF THE LITERATURE
 
Section 1: Normal Swallowing  
Anatomy, Physiology and Neurologic Control  
The act of swallowing is an integrated, dynamic, and complex mechanism, involving a 
series of sequential, coordinated sensorimotor events, including a combination of 
volitional and reflexive movements of more than 30 nerves and muscles (Malandraki & 
Robbins, 2013; Matsuo & Palmer, 2008; Sasegbon & Hamdy, 2017). The neural control of 
swallowing recruits from all levels of the nervous system, including the cerebral cortex 
(e.g., primary sensorimotor cortex, prefrontal cortex, sensorimotor integration areas, and 
parieto-occipital region), subcortical regions (e.g., insula and frontal operculum, anterior 
cingulate cortex, basal ganglia, thalamus, hypothalamus, amygdala, cerebellum, and 
supplementary motor areas), brainstem, and peripheral nervous system (PNS) 
(Dehaghani et al., 2016; Malandraki & Robbins, 2013; Matsuo & Palmer, 2008; Mistry & 
Hamdy, 2008; Sasegbon & Hamdy, 2017). The brainstem swallowing center, which is 
considered the core of the swallowing system, contains the central pattern generators 
(CPGs) that – along with the premotor circuitry and motor neurons – control and 
coordinate the phases of swallowing (Lang, 2009; Mistry & Hamdy, 2008). With regard to 





is bilateral, though asymmetric, with some studies suggesting greater activity in the right 
hemisphere (Ertekin & Aydogdu, 2003; Mistry & Hamdy, 2008; Sasegbon & Hamdy, 
2017). Mosier and Bereznaya (2001) describe cortical control of swallowing as five 
clusters of independent brain regions, with the regions within each cluster working in 
excitatory and inhibitory coordination (Cichero & Murdoch, 2006). The clusters are 
organized as follows: A – primary motor, sensory, and supplementary cortices and 
cingulate gyrus; B – inferior frontal gyrus, secondary sensory cortex, corpus callosum, 
basal ganglia, and thalamus; C – premotor and posterior parietal cortices; D – 
cerebellum, and E – insula (Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001). The 
authors also suggest that certain clusters influence others. For example, the cortical 
regions of Cluster A are involved in volitional motor behavior, planning, and execution; 
sensory, motor, and cognitive processing; and are thought to act as sensorimotor output 
that affect Cluster B, which facilitate sensory information integration about the bolus 
(Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001). Furthermore, excitation of 
Cluster B provides an inhibitory effect on Cluster D, while Cluster C has the opposite 
(excitatory) effect on Cluster A, potentially involving motor planning and implementation 
(Cichero & Murdoch, 2006; Mosier and Bereznaya, 2001). Cluster D (cerebellum) controls 
motor coordination, timing, sequencing, and proprioception, which modulates the 
internal representation for swallowing versus the actual execution of swallowing, 
impacting both Clusters A and B (Cichero & Murdoch, 2006; Mosier and Bereznaya, 
2001). Finally, Cluster E (insula) affects Clusters A and C, potentially for the purpose of 




The swallowing process is divided into three phases: oral, pharyngeal, and esophageal, 
with the oral stage containing two phases: oral preparatory and oral transport (ASHA, 
n.d). The volitional actions during the oral phase, such as the stereotypic motor pattern 
of mastication, are controlled by discrete areas of the cerebral cortex and CPGs in the 
reticular formation and trigeminal nucleus of the brainstem (Jean, 2001; Lang, 2009). The 
events of the semi-reflexive pharyngeal phase are triggered and controlled by the 
activation of cortical and subcortical brain regions, primarily the CPG in the nucleus 
tractus solitarius located in the medulla oblongata of the brainstem (Jean, 2001; Lang, 
2009; Mistry & Hamdy, 2008). The involuntary or reflexive esophageal phase is also 
coordinated by the swallowing CPG located in the nucleus tractus solitarius of the 
medulla oblongata (Jean, 2001; Lang, 2009; Mistry & Hamdy, 2008).   
 
In the oral stage of swallowing, saliva, teeth, and three main muscle groups are 
responsible for the execution of oral acceptance, containment, mastication, 
manipulation, and bolus formation (Malandraki & Robbins, 2013; Sasegbon & Hamdy, 
2017). The first muscle group needed for the oral preparatory and oral transport phases 
includes the lips and cheeks, which are comprised of the orbicularis oris, buccinator, 
risorius, lip elevators, and lip depressors, and are innervated by the Facial Nerve (CN VII) 
(Sasegbon & Hamdy, 2017). The second muscle group is the tongue, which includes the 
transverse, vertical, superior, and inferior longitudinal muscles; genioglossus; hyoglossus; 
styloglossus; and palatoglossus and are innervated by the Facial (CN VII) (taste), 
Glossopharyngeal (CN IX) (taste), Vagus (CN X) (innervates palatoglossus, taste and 
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sensation for base of tongue), and Hypoglossal (CN XII) (muscle contractions) nerves 
(Sasegbon & Hamdy, 2017). The third muscle group is the mandibular muscles, 
comprised of the temporalis, masseter, lateral pterigoids, and medial pterigoids, and 
innervated by the Facial nerve (CN VII) and the mandibular branch of the Trigeminal 
nerve (CN V3) (Sasegbon & Hamdy, 2017). 
 
The oral phase of swallowing begins with the sensory recognition of food or liquid, as the 
olfactory and taste systems work in concert, which causes salivation triggered by 
olfaction and taste via sensory fibers in the oropharynx that respond to temperature 
and/or touch-pressure and chemoreceptors that respond to smell and taste (Malandraki 
& Robbins, 2013). Saliva is produced in anticipation of and throughout eating. Saliva is an 
important component of the swallowing process because it aids in mastication (by 
softening and breaking down food), formation of a bolus, and lubrication (for bolus 
passage into the pharynx) (Sasegbon & Hamdy, 2017). From the oropharyngeal sensory 
fibers, the Trigeminal (CN V), Facial (CN VII), Glossopharyngeal (CN IX), and fibers shared 
by the Vagus (CN X) and Accessory (CN XI) nerves receive sensory and taste information, 
which is transmitted to groups of nuclei in the brainstem (e.g., regions of the nucleus 
tractus solitarius, nucleus ambiguus, and reticular formation of both these groups of 
nuclei) (Malandraki & Robbins, 2013). These nuclei receive supramedullary input and 
transmit motor commands via the Trigeminal (CN V), Facial (CN VII), Glossopharyngeal 
(CN IX), fibers shared by the Vagus (CN X) and Accessory (CN XI), and the Hypoglossal (CN 
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XII) nerves to the terminal organs (i.e., nearly 40 pairs of oropharyngeal muscles) 
(Malandraki & Robbins, 2013). 
 
Teeth, which are innervated by the maxillary and mandibular branches of the Trigeminal 
nerve (CN V), are also important structures in the swallowing process because they 
physically crush and grind food during mastication, allowing for bolus formation 
(Sasegbon & Hamdy, 2017). After food is introduced into the oral cavity and the lips, 
teeth, and tongue take the bolus from the utensil, oral containment via labial seal 
prevents anterior spillage out of the oral cavity and mastication, using rotary lateral 
mandibular movement, occurs while lingual manipulation positions food on the molars 
for crushing and grinding. Mastication is a volitional motor task controlled by the 
brainstem CPG and supplemented by the motor cortex; however, once initiated, it 
becomes largely automatic relying on preprogrammed movement patterns (Mistry & 
Hamdy, 2008). During this time, sensory feedback prevents tongue injury during 
mastication and indicates when the bolus has been adequately masticated. These oral 
preparatory actions are performed through labial, buccal, lingual, mandibular, and velar 
movements, which form the bolus (Malandraki & Robbins, 2013). Regarding liquids, the 
oral phase is much simpler and faster than with solid foods as mastication is not required. 
In normal swallowing, the liquid bolus is introduced through the lips where it is contained 
behind closed lips (i.e., labial closure), held in the anterior floor of the mouth or between 
the dorsal lingual surface and hard palate, and then is pulled together into a bolus prior 
to the initiation of the pharyngeal swallow (Matsuo & Palmer, 2008).  
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During the oral transport phase, the tongue initiates the anterior to posterior propulsion 
of the bolus from the oral cavity to the pharynx. At the beginning of this phase, the bolus 
is on the anterior tongue. The tip of the tongue either tips up or down (e.g., “tipper” 
versus “dipper”) positioning the bolus on the superior lingual surface while the posterior 
tongue lowers, which occurs via intrinsic lingual muscles (i.e., attached to other muscles 
in the tongue, including the superior and inferior longitudinal, vertical and transverse 
muscles) and extrinsic lingual muscles (i.e., attached to structures [like the hyoid bone], 
including the hyoglossus, styloglossus, genioglossus, and palatoglossus) (Malandraki & 
Robbins, 2013; Sasegbon & Hamdy, 2017). The tongue sequentially squeezes against the 
hard palate causing anterior to posterior flexion that forces the bolus posteriorly toward 
the pharynx (Sasegbon & Hamdy, 2017). As the bolus progresses posteriorly, the sensory 
fibers in the oropharynx and tongue that respond to temperature and/or touch-pressure 
are stimulated and trigger the initiation of the pharyngeal swallow (Malandraki & 
Robbins, 2013; Sasegbon & Hamdy, 2017). While this process is occurring, the velum 
elevates, contacts the nasopharynx, and seals the nasopharynx preventing food/liquid 
from entering (Sasegbon & Hamdy, 2017). 
 
The pharyngeal phase of swallowing involves numerous sensorimotor and physiologic 
behaviors that occur simultaneously between the hypopharynx and the larynx to 
transport the bolus from the oropharynx to the esophagus (Logemann, 1998). At the 
initiation of the pharyngeal phase, the velum is elevated and in contact with the lateral 
and posterior pharyngeal walls, providing complete closure of the velopharyngeal port 
 11 
 
(Matsuo & Palmer, 2008). Lingual-palatal contact propels the bolus against the posterior 
pharyngeal wall, which contributes to the positive pressure that pushes the bolus 
downward (Malandraki & Robbins, 2013). Laryngeal elevation and anterior hyoid 
movement, via the extrinsic laryngeal muscles and thyrohyoid muscles, contribute to 
airway protection and opening of the upper esophageal sphincter (UES) - comprised of 
the inferior pharyngeal constrictor muscles, cricopharyngeus muscle, and the most 
proximal part of the esophagus - for passage of the bolus from the pharynx to the 
esophagus (Malandraki & Robbins, 2013). Adequate laryngeal closure is critical for airway 
protection; therefore, it occurs at three anatomical levels: the true vocal folds, the false 
vocal folds, and the epiglottis (Malandraki & Robbins, 2013). While all of this is occurring, 
the pharyngeal constrictors begin contracting in a descending arrangement, the laryngeal 
framework is pulled upward, the epiglottis inverts to seal the laryngeal vestibule, 
pharyngeal stripping waves and pharyngeal contraction propel the bolus, and finally the 
UES (closed at rest by tonic muscle contraction) opens, via relaxation of the 
cricopharygeus muscle, to allow the bolus to pass from pharynx to the esophagus 
(Malandraki & Robbins, 2013; Sasegbon & Hamdy, 2017).  
 
The esophageal phase begins upon entry of the bolus through the UES. Afferent neurons 
transmit the sensation of the arrival of the bolus in the esophagus to the 
neurophysiological swallowing centers, which activate vagal efferent fibers producing a 
proximal to distal sequence of contractions or peristaltic wave (i.e., “primary peristalsis”) 
that propels the bolus toward the stomach (Malandraki & Robbins, 2013). When 
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peristalsis is initiated, the lower esophageal sphincter (LES) relaxes and the bolus moves 






Section 2: Abnormal Swallowing (Dysphagia)
Stroke-Related Changes in Anatomy, Physiology, and Neurologic Control 
Because swallowing is an extremely complex neuromechanism, involving the integration 
of many coordinated sensorimotor events, including that of several brain regions (such as 
the cortex, subcortical regions, and brainstem), more than 30 nerves and muscles, and 
neural control from the peripheral nervous system (PNS) (Malandraki & Robbins, 2013; 
Matsuo & Palmer, 2008; Sasegbon & Hamdy, 2017; Wilmskoetter et al., 2019b), it is clear 
that a disruption in this process caused by stroke could result in serious impairments in 
swallow (Wilmskoetter et al., 2020), thus, impacting a patient’s ability to safely and 
efficiently eat and drink, potentially affecting nutrition and hydration. Neurologic insults 
can disrupt neuronal transmission of information to and from the central nervous 
system, resulting in impaired muscle and sensory function in the oropharyngeal system 
(Malandraki & Robbins, 2013). In addition, patients with neurogenic (or post-stroke) 
dysphagia frequently present with concomitant language and/or cognitive deficits, which 
may further exacerbate symptoms and outcomes (Malandraki & Robbins, 2013). 
Understanding not only the symptomatology but also the neurophysiological 
underpinnings of post-stroke dysphagia is important because the trajectory of recovery 
and clinical outcomes vary depending on brain lesion sites, severity, and complexity 
(Logemann, 1998).  
 
The literature posits that swallowing is modulated by a complex bilateral neural network 




musculature is represented bilaterally (yet asymmetrically) in the cerebral cortex; 
therefore, a lesion the ‘‘dominant swallowing hemisphere’’ may result in dysphagia 
following a unilateral hemispheric stroke (Cohen et al., 2016). Furthermore, several 
scientific studies have revealed that right hemisphere stroke lesions are associated with 
greater pharyngeal involvement, including longer pharyngeal transit times, greater risk 
for penetration or aspiration, and/or more severe dysphagia (Malandraki & Robbins, 
2013; Robbins et al., 1993; Suntrup-Krueger et al., 2017; Wilmskoetter et al., 2019b), 
while left hemisphere lesions are associated with oral phase impairments, particularly 
decreased lingual coordination and oral apraxia (Malandraki & Robbins, 2013). It is 
reported that several different lesion locations can potentially cause dysphagia in stroke 
patients, including the somatosensory and motor cortices, anterior cingulate, thalamus, 
insula, internal capsule, brainstem, cerebral cortex (including insula, posterior central 
gyrus, precentral gyrus, cingulate gyrus, supramarginal gyrus, angular gyrus), and 
subcortical structures (including basal ganglia; Liu et al., 2017; Wilmskoetter et al., 
2019b).  
 
The knowledge that stroke lesion location can influence the type and severity of 
dysphagia is beneficial for clinicians diagnostically, to facilitate more accurate predictions 
of physiological swallow impairments after stroke, and for treatment planning as well. For 
example, strokes in the cerebral cortex have been shown to result in both oral and 
pharyngeal dysphagia; however, their impact on the oral phase, such as reduced labial 
closure, reduced oral containment, and lingual incoordination, is theorized to be due to 
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the loss of cortical modulation of the oral swallow neurons (Sasegbon & Hamdy, 2017). 
Understanding information about lesion location and how it relates to swallowing 
impairment is important for clinicians initiating intervention because although symptom 
onset is acute in patients with post-stroke dysphagia, and some recovery is expected due 
to the cortical reorganization that generally occurs after stroke (Cohen et al., 2016; 
Malandraki & Robbins, 2013), patients still benefit from intervention and management 
for transient dysphagia symptoms. Furthermore, even though many stroke patients 
recover swallowing function spontaneously during the acute phase (up to 90% of patients 
after two weeks) and a number of patients continue to recover at four weeks, 11–50% of 
patients present with persistent dysphagia at six months with a small proportion of 
patients remaining with dysphagia longer than six months (Bahcecı et al., 2017; Cohen et 
al., 2016). The reason is not frequently obvious why some patients experience persistent 
dysphagia and others do not, though there may be other contributing factors, including 





Section 3: Post-Stroke Depression
Stroke-Related Changes in Anatomy, Physiology, and Neurologic Control 
PSD is defined as a “prominent and persistent period of either depressed mood or 
markedly diminished interest or pleasure in most or all activities that (1) is believed to be 
the direct physiologic consequence of stroke, (2) is not better explained by another 
psychiatric illness or as a feature of delirium, and (3) causes clinically significant distress 
or impairment (Nemani & Gurin, 2021, p. 87). The etiology of PSD is not well-understood; 
therefore, there is currently no consensus among experts regarding its cause or exactly 
what areas of the brain are associated with PSD. However, researchers believe that PSD is 
multi-factorial, involving biological and psycho-social factors, such as inflammation, 
response to ischemia (as with stroke), genetic susceptibility, neurogenesis, and 
involvement of the hypothalamo-pituitary-adrenal (HPA) axis (Das & Rajanikant, 2018; 
Towfighi et al., 2018). Furthermore, it is suggested that the role of proinflammatory 
cytokines in (stroke-induced) neuroinflammation and neurodegeneration is a major 
factor in PSD (Das & Rajanikant, 2018; Towfighi et al., 2018). Multiple scientific studies 
have identified brain regions, including the prefrontal cortex, dorsolateral prefrontal 
cortex, amygdala, thalamus, hippocampus, anterior cingulate cortex, and basal ganglia, 
that may be involved in the neuromechanism of PSD (Douven et al., 2017; Robinson & 
Jorge, 2016; Shi et al., 2017b). Additionally, investigators have demonstrated that left 
hemisphere lesions are linked with a higher incidence of depression, and location of 
subcortical lesions have a greater influence on PSD (Das & Rajanikant, 2018). Recent 




activity of the underlying neural networks, resulting in poorer patient prognosis (Shi et 
al., 2017b). For example, a stroke lesion in the prefrontal cortex, which has dense axonal 
connections to the limbic system, may result in disrupted transmission of information 
pertaining to emotions, behavior, and motivation (associated with the limbic system; Shi 
et al., 2017b). A study by Wilmskoetter et al. (2019a) performed neuroimaging mapping 
of stroke lesions and revealed that brain lesions in cortical structures connected to the 
limbic system are associated with reduced improvement in oral intake in dysphagic 
patients after stroke. Since there is currently no known literature related to PSD in post-
stroke dysphagic patients, it may be possible that PSD in post-stroke dysphagic patients 
with brain lesions in regions connected to the limbic system is an under-diagnosed 
comorbidity that negatively affects stroke recovery, specifically swallow function 
recovery, in this patient population.  
 
Although the relationship between PSD and post-stroke swallow function recovery has 
not yet been investigated, there have been a number of studies examining PSD and 
general functional recovery after stroke. The literature suggest that PSD negatively 
affects patients in many ways, including decreased neuroplasticity; physical, social, and 
cognitive function; participation in rehabilitation therapies; and ability to perform 
activities of daily living (ADLs; Bhogal et al., 2004; Parikh et al., 1990; Towfighi et al., 
2017; Žikić et al., 2014). The majority of studies suggest significantly greater functional 
disability in patients with PSD versus non-depressed patients (Žikić et al., 2014). 
Accordingly, PSD is associated with poorer functional outcomes and QOL and increased 
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healthcare utilization and mortality rates (Bhogal et al., 2004; Parikh et al., 1990; Towfighi 
et al., 2017).  
 
There has been much research in the neurology literature examining PSD and functional 
recovery, specifically motor recovery. For example, in a randomized controlled trial (RCT), 
Chollet et al. (2011) compared fluoxetine (a selective serotonin reuptake inhibitor (SSRI) 
antidepressant) to placebo in acute, ischemic stroke patients with PSD and moderate to 
severe hemiplegia. The study findings revealed significantly improved motor function in 
the fluoxetine group, suggesting that fluoxetine has (or SSRIs in general have) a positive 
effect on motor recovery (Chollet et al., 2011). Similarly, a meta-analysis by Mead et al. 
(2012) was conducted to determine if SSRIs improve recovery (i.e., reduce dependency 
and disability) after stroke. The researchers found evidence that SSRI use after stroke 
may improve dependence, disability, neurological impairment, anxiety, and depression 
(Mead et al., 2012). Despite promising evidence in the literature, however, it is not yet 
fully understood whether improvements in function from SSRIs are due to the role of 
pharmacotherapy on neuroplasticity or if PSD impedes motor function recovery and 
pharmacotherapy reverses those effects (Towfighi et al., 2017). Further research is 
needed to examine the role of PSD in post-stroke recovery and to determine the factors 
influencing whether PSD worsens functional outcomes (Chollet et al., 2011; Towfighi et 
al., 2017). Likewise, additional research is warranted to explore the role of PSD in post-








Aim 1: Determine the rate of PSD in patients with post-stroke dysphagia. 
• Hypothesis 1: The rate of PSD in patients with post-stroke dysphagia is at least as 
high as the rate of PSD in the general stroke population. 
 
Aim 2: To categorize dysphagia severity in an inpatient post-stroke population using 
dysphagia-specific ICD-10 diagnosis and procedure codes and to determine if dysphagia 
severity impacts diagnosis of PSD.  
• Hypothesis 1: A stable subset of dysphagia diagnosis and procedure codes will 
identify groups of patients with distinct dysphagia severity characteristics. 
• Hypothesis 2: Patients who fall in different dysphagia severity groups will have 
different risk of PSD diagnosis after discharge. 
o Hypothesis 2a: Post-stroke patients with more severe dysphagia will have 
a greater proportion of PSD diagnosis within the 90 days after discharge. 
o Hypothesis 2b: Post-stroke patients with more severe dysphagia will have 





o Hypothesis 2c: Post-stroke patients with more severe dysphagia and a 
diagnosis of PSD will have a shorter time to first depression diagnosis. 
 
Aim 3: Compare the mean healthcare costs in post-stroke dysphagic patients with and 
without PSD. 
• Hypothesis 1: Dysphagic patients with PSD will incur greater healthcare costs than 






We conducted a retrospective, cross-sectional study of individuals with a primary 
diagnosis of acute ischemic stroke (AIS) using administrative data from the 2017 
Medicare 5% Limited Data Set (LDS), the most recent data set available at the start of this 
study. Per the university Institutional Review Board, this study was not considered human 
subject research. 
 
Description of Administrative Database  
The Centers for Medicare & Medicaid Services (CMS) provide LDS files for research. LDS 
files include de-identified (i.e., no specific direct identifiers as defined in the Health 
Insurance Portability and Accountability Act (HIPAA) Privacy Rule (CMS.gov, 2020), 




For this study, we used several medical code sets, including International Classification of 
Diseases, Tenth Revision, Clinical Modification (ICD-10-CM); International Classification of 
Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS); Healthcare Common 
Procedure Coding System (HCPCS); and Current Procedural Terminology (CPT). (See 
Appendices 1-3 for tables containing all codes used in this study.) ICD-10-CM and ICD-10-
PCS codes are U.S. versions of the International Classification of Disease, Tenth Revision 




mortality and morbidity (Steindel, 2010). ICD-10-CM is used for diagnostic coding while 
ICD-10-PCS is used for inpatient procedures (LaPointe, 2018). HCPCS is used to code 
procedures, services, supplies, and materials and has three levels: Level I CPT codes, 
Level II National codes, and Level III Local codes (not nationally accepted and rarely used) 
(PMIC, 2019). HCPCS Level I CPT (simplified as “CPT”) codes are used to code physician 
and allied healthcare professional procedures and services. HCPCS Level II codes are used 
for supplies, equipment, materials, and services not represented in CPT codes. 
 
Patient Population 
We included Medicare beneficiaries 65 years of age and older who were discharged from 
the hospital with a primary diagnosis of AIS. Within this population, we examined 
patients with diagnosis of dysphagia and/or depression during inpatient hospitalization 
and within 90 days after discharge. Individuals with a history of dysphagia or depression 
within 90 days prior to stroke were excluded. 
 
Outcome Measures 
Our outcomes of interest included diagnosis of dysphagia and/or depression during the 
inpatient hospitalization or within a 90-day follow-up window after discharge; dysphagia 
severity (indicated by feeding status [e.g., feeding tube use], nutrition [e.g., diagnosis of 
malnutrition], and respiratory compromise [e.g., aspiration pneumonia, intubation, etc.]; 




Aim 1: Data Set Construction 
We constructed the data set for Aim 1 in four steps (Figure 1). First, we identified ICD-10-
CM diagnosis codes relevant to our diagnoses of interest (e.g., AIS, dysphagia, 
depression). Second, we pulled claim-level diagnosis, procedure, Diagnosis Related 
Groups (DRGs), dates of service, reimbursement amounts, and provider data from 
Standard analytic files (SAFs) and patient demographic data from Denominator files for 
relevant outcomes of interest. Third, we extracted outpatient claims data less than or 
equal to 90 days prior to stroke, removed patients who had a diagnosis of dysphagia or 
depression prior to stroke, and pulled data relevant to our outcomes of interest. Finally, 
we reviewed discharge dates, extracted claims data within a 90-day follow-up window 
after discharge, and identified patients with dysphagia and/or depression.  
 
 Figure 1. Flow chart of the construction of the Aim 1 data set. 
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Aim 2: Data Set Construction 
For Aim 2, we studied a population of patients diagnosed with post-stroke dysphagia 
during two different time points: (1) during acute hospitalization and (2) within the 90-
day time period after discharge from the acute hospital. For inpatient data set 
construction, first, we extracted all AIS survivors with a diagnosis of dysphagia and NIHSS 
score (a measure of stroke severity) (N=445) from our original (Aim 1) data set. We 
limited our analysis to this group of patients to ensure that we would have a valid 
measure of stroke severity (the NIHSS score) for external construct validity of our 
dysphagia groups. The selection of this patient subgroup for the development of a 
severity grouping also helps assure that the population represents patients seen in 
hospitals that have adopted the most recent recommendations for the ICD-10 coding for 
AIS severity, which minimizes variations due to coding conventions. Second, we compiled 
ICD-10-CM and ICD-10-PCS codes relevant to dysphagia (Appendix 4), based on the 
literature (Cohen et al., 2020; Gonzalez-Fernandez et al., 2009; Pu, et al., 2017) and 
clinical expertise. Third, we created dichotomous variables that represented common 
dysphagia sequelae, subgroup diagnoses, and procedures using the compiled codes 
(Appendix 4) to identify post-stroke patients in the acute hospital with specific dysphagia-
related outcomes. For example, the variable Respiratory Problems included ICD-10-CM 
codes for respiratory conditions such as acute respiratory distress syndrome (ARDS), 
respiratory failure, dyspnea, and acute respiratory distress. Fourth, we programmed 
individual array coding schemes in SAS for each type of code set (ICD-10-CM and ICD-10-
PCS). For the post-discharge data set, we examined the same patient sample from the 
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previous Aim 2 data set and pulled additional post-discharge data, including Healthcare 
Common Procedure Coding System (HCPCS) and Current Procedural Terminology (CPT) 
codes relevant to dysphagia (Appendix 4) and outpatient visits (e.g., first visit coded with 
depression). We also removed patients who had died, were discharged to hospice, 
and/or had missing follow-up data (final N=359). 
 
Aim 3: Data Set Construction 
The Aim 3 data set was constructed using the post-discharge Aim 2 data set of AIS 
survivors who had received a diagnosis of post-stroke dysphagia while in the acute 
hospital and had a documented NIHSS score (a measure of stroke severity) in their 
electronic record (n=359). We extracted each patient’s Medicare administrative claims 
data for the 90 days after discharge from the Index hospital admission to summarize 
healthcare costs from the perspective of the medical care system (measured as claims 
paid by Medicare plus the coinsurance and deductible amounts paid by patients, in 
United States dollars [USD]). We used claims data from the Medicare service-specific 
data tables to calculate total costs (defined as payments) for the 90-day post-discharge 
period. Data sets used were (1) inpatient costs after discharge (e.g., inpatient 
rehabilitation admission or admission to an acute hospital), (2) outpatient costs, (3) home 
health costs, (4) skilled nursing facility (SNF) costs, and (5) Part B (carrier) costs. Data 
from each service table were aggregated at the patient level by summing total payments 
for the service type. Patients who did not use a service were then assigned $0 cost for 
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Statistical Approaches and Data Analysis
All statistical analyses were conducted using SAS statistical software (version 9.4, 
released 2016, SAS Institute, Inc., Cary, N.C., USA). Univariate analyses for demographics 
and clinical characteristics were conducted. Frequency tables were used for categorical 
variables to determine proportions (frequency and percentages) while mean, standard 
deviation, and range were computed for continuous variables. P-values were considered 
statistically significant for α<0.05. 
 
Variable Definitions 
Variables were defined as follows: 
• Dysphagia: Patient administrative data contained billing codes related to 
dysphagia (Cohen et al., 2020; Gonzalez-Fernandez et al., 2009; Appendix 1); 
dichotomous. 
• Depression: Patient administrative data contained billing codes related to 
depression (Appendix 1); dichotomous. 
• Cognitive decline: Patient administrative data contained billing codes related to 
cognitive decline (Appendix 1); dichotomous. 
• Days to depression: Number of days from admission date for AIS to first visit 
coded for depression; continuous. 
• Charlson Comorbidity Index (CCI): A validated index for predicting the outcome 
and risk of mortality from many comorbid diseases (Charlson et al., 1987; Quan et 




• Stroke Administrative Severity Index (SASI): A validated measure of stroke severity 
at hospital discharge (Simpson et al., 2018); continuous.  
• National Institutes of Health Stroke Scale (NIHSS): A reliable 15-item scale used to 
identify the severity of neurological symptoms after stroke, estimate prognosis, 
and predict recovery in acute stroke patients (Brott et al., 1989); continuous. 
• Length of stay (LOS): Period of a single hospitalization; continuous. Longer 
hospitalizations are considered a marker for poor outcomes.  
• Dual eligibility: Beneficiary of both Medicare and Medicaid, which indicates low 
socioeconomic status (Moon & Shin, 2006); dichotomous. 
• Tissue plasminogen activator (tPA) administration: Treatment for ischemic stroke 
that dissolves the clot and improves blood flow; dichotomous. Used as proxy for 
better quality of care in research and a marker for better expected outcomes. 
 
Aim 1 Data Analysis 
For Aim 1, we calculated proportions using frequency tables to determine the rate of PSD 
in patients with post-stroke dysphagia. We compared demographics and clinical 
characteristics using t-tests for continuous variables and chi-square for categorical 
variables. In addition, we estimated regression coefficients and adjusted odds ratios (OR) 
using logistic regression to determine if PSD is associated with post-stroke dysphagia and 
if patients diagnosed with post-stroke dysphagia are more likely to be diagnosed with 
PSD. Finally, we performed time-to-event (survival) analyses (including the Cox 
proportional hazards model) to assess the time to depression after stroke and estimate 
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The two-sample t-test is a widely used parametric test that compares the means of two 
data sets to determine if they are equal, which indicates no difference (Winters et al., 
2010). We compared the means of the continuous variables age, CCI, SASI, and LOS in 
dysphagic and non-dysphagic patients to determine if differences were significant 
between groups. 
 
Chi-Square Test for Independence 
The chi-square test is a nonparametric test used to determine if there is a significant 
association between categorical variables, testing the distributions of independent data 
sets against a theoretical distribution (Winters et al., 2010). A larger chi-square statistic 
indicates that distributions are more alike or related, with a value of 0 suggesting no 
relationship (Winters et al., 2010). We tested relationships between the categorical 
variables gender, race, depression, cognitive decline, tPA administration, and dual 
eligibility in dysphagic and non-dysphagic patients to determine if associations were 







Logistic regression is used to describe the relationship between a dichotomous outcome 
variable and one or more predictor variables (covariates; Hosmer et al., 2013). In logistic 
regression, multiple covariates can be included in a single model, which allows for 
simultaneous adjustment of multiple potential confounders (Wiest et al., 2015).  
 
In our first step to build a logistic regression model (Proc Logistic in SAS), we used 
purposeful selection to include clinically relevant predictor variables (Hosmer et al., 2013; 
Stoltzfus, 2011) in our initial model, such as age (in years); gender (male/female); race 
(white, black, Hispanic, or other); CCI (score); SASI (score); tPA (yes/no); LOS (in days), 
and dual eligibility (yes/no). Next, for model building, we used a direct approach, 
simultaneously placing all predictor variables identified for inclusion with equal 
importance into a multivariable model (Hosmer et al., 2013; Stoltzfus, 2011). Then we 
checked for multicollinearity between predictor variables by examining several values, 
including variables with high correlation (>0.8 indicating multicollinearity), a Variance 
Inflation Factor (VIF) greater than 10, tolerance values greater than 0.1, and small 
Eigenvalues (close to 0) with large corresponding condition values (indicating 
multicollinearity; Schreiber-Gregory, 2017). Given that multicollinearity was not detected, 
we continued with model building, using a less stringent variable inclusion criterion 
(alpha of <0.25) so as not to exclude potentially important variables at this initial stage of 
model development (Hosmer et al., 2013; Mickey & Greenland, 1989; Stoltzfus, 2011). 
Variables that were not significant at p<0.25 were manually removed one at a time, and 
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the model was refit using the traditional level of statistical significance (p<0.05) until a 
parsimonious model was constructed.  
 
To determine how well the final model fit the data, we took a random 10% sample of the 
population and applied the Hosmer–Lemeshow (HL) goodness-of-fit (GOF) test, which is a 
chi-square-based test that divides the population into subgroups based on estimated 
probability of success and assesses if observed event rates match expected event rates 
(Hosmer et al., 2013; Montgomery et al., 2012; Stoltzfus, 2011). If the model fit is good, 
then the HL statistic will follow a chi-square distribution; however, a small p-value (< 
0.05) indicates a poor fit (Hosmer et al., 2013; Montgomery et al., 2012). A criticism of 
the HL GOF test is that it has low power (Stoltzfus, 2011); however, in our case, low 
power is not a concern because of our large data set (N=9,163). The concern would be 
that because power increases as sample size increases, small deviations from the model 
in a large data set will appear significant (Paul et al., 2013). We have addressed this 
limitation by conducting the HL GOF test with a smaller 10% random sample of our data 
set (n=917). 
 
Time-to-Event (Survival) Analysis 
Time-to-event (survival) analysis refers to statistical procedures that analyze the time 
until a well-defined endpoint (event) occurs (Schober & Vetter, 2018). These specific 
analyses are required because of the unique features of time-to-event data. For example, 
not all individuals will experience the event of interest during the study observation 
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period, resulting in unknown/incomplete observations for some individuals (called 
“censoring”), which must be resolved through the application of appropriate statistical 
techniques (Schober & Vetter, 2018). 
 
Cox Proportional Hazards Model 
The Cox proportional hazards model (Cox, 1972) is a common semiparametric method 
for analyzing time-to-event data that does not makes assumptions about the distribution 
of survival times (Schober & Vetter, 2018). It is a regression model used to assess the 
relationship among multiple predictors to a time-to-event outcome (Vittinghoff et al., 
2005). The Cox model provides the hazard ratios (HRs) (and 95% confidence intervals 
(Cis)) of an individual experiencing an event given a set of covariates and assumes a 
relationship between covariates and the hazard function (Fisher & Lin, 1999; Schober & 
Vetter, 2018). In this study, the starting point was admission to the hospital with a 
primary diagnosis of AIS, and the terminal event was the first post-stroke visit coded for 
depression.  
 
First, we used time-to-event analysis (Proc Lifetest in SAS) to estimate the unadjusted 
time to diagnosis of depression (event) from the initial diagnosis of stroke (in days) by 
dysphagic versus non-dysphagic groups without controlling for covariates. Second, we 
constructed conventional Cox proportional hazards models (Proc Phreg in SAS) to 
determine which covariates (age, gender, race, CCI, SASI, tPA, LOS, or dual eligibility) 
significantly affect the time of PSD diagnosis using adjusted HRs. Third, we manually 
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removed each covariate if it did not meet inclusion criteria defined as adequate model fit 
statistic, likelihood ratio tests, and statistical significance (<0.05). Fourth, we tested for 
interaction effects between covariates, and last, we included all significant covariates in 
the final parsimonious model. After the final model was constructed, we performed 
diagnostics to check for adequacy of the model. 
 
A fundamental assumption of Cox regression is that hazards between groups are 
constant (or proportional) over time (Bellera, et al., 2010; UCLA: Statistical Consulting, 
n.d.-a; Schober & Vetter, 2018). If this assumption of proportionality is violated, biased 
and/or incorrect estimates may be derived resulting in misleading interpretations 
(Bellera, et al., 2010; UCLA: Statistical Consulting, n.d.-a). Thus, we assessed the 
proportionality of the hazards using graphical checks for categorical covariates by which 
Kaplan-Meier survival curves are plotted for each level of categorical covariate, and then 
the survival function graphs were judged as to whether or not the survival curves appear 
parallel (with a parallel graph indicative of proportionality) (Bellera, et al., 2010; Fisher & 
Lin, 1999; UCLA: Statistical Consulting, n.d.-a). Typically, graphical checks alone are not 
sufficient to assess proportionality due to their subjectivity (Bellera, et al., 2010); 
however, it was evident that survival function graphs for all categorical covariates we 
assessed (dysphagia, gender (female), race (white), dual eligibility) were not parallel 
(displayed crossed curves). This was suggestive of non-proportionality, meaning there 
was an interaction between these covariates and time (Bellera, et al., 2010; UCLA: 
Statistical Consulting, n.d.-a). For the continuous covariate (age), we applied the 
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empirical score process using a transform of the martingale residuals as a diagnostic for 
proportionality (Lin et al., 1993). Then we inspected the simulation graph for an aberrant 
observed pattern and checked the corresponding supremum test results for significance 
(p<0.05), indicative of a violation of the proportional hazards assumption (Allison, 2010; 
Introduction to Survival, n.d.; Lin et al., 1993). No violation was detected for the 
continuous covariate (age). 
 
To account for the non-proportionality of four of the covariates (dysphagia, female, 
white, dual eligibility), we created time-dependent variables that explicitly introduced 
covariate-by-time interactions into the Cox model, which generalizes the model to permit 
the use of non-proportional hazards, thereby addressing the proportionality violation 
(Allison, 2010; Bellera, et al., 2010; Cox, 1972; UCLA: Statistical Consulting, n.d.-a). After 
running the Cox models again with each covariate-by-time interaction term, we found 
that the interaction covariates for dysphagia and white remained significant, indicating 
non-proportionality; however, our use of the method for extending the Cox model by 
including covariate-by-time interactions as predictors allowed for the incorporation of 
non-proportionality in the Cox model (Allison, 2010; UCLA: Statistical Consulting, n.d.-a). 
 
Aim 2 Data Analysis  
For Aim 2, we developed a novel dysphagia severity index for use with administrative 
data to categorize patients with similar dysphagia severity during acute hospitalization 
(hypothesis 1) and then used the severity index to examine the risk for receiving a 
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diagnosis of depression after discharge in patients diagnosed with post-stroke dysphagia 
(hypothesis 2). We described demographics and clinical characteristics using frequencies 
and proportions, comparing results for categorical variables using chi-square or Fisher’s 
exact test, and we calculated means and standard deviations for continuous variables, 
comparing means using t-tests. Bivariate comparisons were performed using one-way 
analysis of variance (ANOVA) for continuous, normally distributed variables; Kruskal-
Wallis for non-normally distributed variables; and chi-square test or Fisher’s exact for 
dichotomous variables. 
 
Billing data does not contain clinical details about disease severity or treatment response; 
therefore, a proxy for severity is needed in order to adequately utilize and analyze claims 
data (Gonzalez-Fernandez et al., 2009; VanDerwerker et al., 2020). There is currently no 
universal standard for dysphagia severity classification in post-stroke patients for use 
with administrative data in the literature; therefore, we developed a novel proxy index 
for dysphagia severity in administrative data with key clinical variables using cluster 
analysis. 
 
Aim 2 Hypothesis 1  
Cluster Analysis 
Cluster analysis is a data exploration technique for organizing data into homogenous 
groups (or clusters) such that objects or individuals grouped together in one cluster 
resemble one another and are distinctly different from objects or individuals grouped in 
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other clusters (Everitt et al., 2010). Cluster analysis facilitates improved understanding of 
the underlying characteristics that define each cluster (Lu, 2018). Unsupervised K-means 
cluster analysis is a method by which a partitioning algorithm divides observations into a 
specified number (k) of clusters (chosen a priori) and then randomly selects k points as 
initial cluster means (centroids), called “cluster seeds” (Frades & Matthiesen, 2010; King, 
2015; MacQueen, 1967). Next, each observation is assigned iteratively to the cluster with 
the closest centroid, based on the minimum Euclidean squared distance, and the 
centroids of the newly formed clusters are recalculated (Abbas, 2008; Everitt et al., 2010; 
Frades & Matthiesen, 2010; King, 2015; Lu, 2018). This process is repeated until the 
centroids have stabilized – allocation of the same or similar observations to each cluster 
occurs in successive rounds (Frades & Matthiesen, 2010) or the sum of the distances 
between the observations and their respective centroids is minimized (Abbas, 2008; King, 
2015). 
 
We performed K-means cluster analysis to categorize patients with dysphagia based on 
indicator dysphagia groups constructed from ICD-10 diagnosis and procedure codes for 
patients during acute hospitalization for AIS. First, we ran a correlation analysis using 
Pearson correlation coefficients (Proc Corr in SAS) to determine if any variables were 
highly correlated. Codes with strong correlation were combined. Next, we performed a 
cluster analysis (Proc Fastclus in SAS) to group billing codes into their respective disjoint 
clusters (SAS Institute, 1999). Using an iterative process, we started with a large number 
of clusters (k=7) and repeatedly estimated the k-means algorithm while reducing k 
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clusters by one for each new iteration until an optimal number of clusters was identified. 
Criteria for the optimal number of clusters was defined as estimated consensus among 
graphical representations of the clusters (SAS Institute, 2015), cubic cluster criterion 
(CCC) (Sarle, 1983), pseudo-F statistic (PSF) (Caliński & Harabasz, 1974), and maximal R-
square value (King, 2015; Lu, 2018; SAS Institute, 2015). Once the final number of clusters 
was agreed upon, the codes were appraised for clinical significance and relevance within 
the clusters, and irrelevant codes (for which very few or no patients were diagnosed) 
and/or codes that yielded poor statistical results (e.g., over-powering R-square value, 
negative CCC, etc.) were removed.  
 
We performed cluster validation to assess the quality of the clustering generated by our 
algorithm (Frades & Matthiesen, 2010). For validation, we tested cluster stability by 
running the algorithm on three random samples of 60% of the data set and compared 
the cluster means of key outcomes to the means of those key outcomes from the initial 
cluster analysis to determine if the algorithm produced similar results (structures) with 
different data sources (Frades & Matthiesen, 2010). Once we concluded that our 
algorithm was valid, we used the algorithm, now referred to as the “Administrative Data 
Dysphagia Severity Scale” (ADDSS), to examine the risk for receiving a diagnosis of 






Aim 2 Hypothesis 2  
We calculated frequencies and proportions to determine if patients with more severe 
dysphagia have a greater proportion of PSD diagnosis within the 90 days after discharge 
(hypothesis 2a). In addition, we used logistic regression to determine if post-stroke 
patients with more severe dysphagia have greater risk of being diagnosed with PSD 
within the 90 days after discharge (hypothesis 2b). Finally, we performed time-to-event 
(survival) analyses to assess the time to depression after stroke to determine if post-
stroke patients with more severe dysphagia and a diagnosis of PSD have a shorter time to 
first depression diagnosis after discharge from the acute hospital (hypothesis 2c). 
 
Logistic Regression 
Logistic regression is used to describe the relationship between a dichotomous outcome 
variable and one or more predictor variables (covariates; Hosmer et al., 2013). In logistic 
regression, multiple covariates can be included in a single model, which allows for 
simultaneous adjustment of multiple potential confounders (Wiest et al., 2015).  
 
In our first step to building our logistic regression models (Proc Logistic in SAS), we used 
purposeful selection to include clinically relevant predictor variables (Hosmer et al., 2013; 
Stoltzfus, 2011), in addition to our primary independent variable of interest, PSD, in our 
initial models, such as age (in years); CCI (score); female (yes/no); race (white, black, 
Hispanic, or other); tPA (yes/no); dual eligibility (yes/no); and dysphagia severity cluster 
(mild, moderate, severe). We checked for multicollinearity between predictor variables 
 39 
 
(Proc Corr and Proc Reg in SAS) by examining several values, including variables with high 
correlation (>0.8 indicating multicollinearity), a Variance Inflation Factor (VIF) greater 
than 10, tolerance values greater than 0.1, and small Eigenvalues (close to 0) with large 
corresponding condition values (indicating multicollinearity; Schreiber-Gregory, 2017). 
Given that multicollinearity was not detected, we continued with model building. Next, 
we fit logistic regression models with key covariates judged to have potentially strong 
impacts on the data. Variables that were not significant at p<0.25 were manually 
removed one at a time, and the models were refit using the traditional level of statistical 
significance (p<0.05). Typically, we would refit the models until a parsimonious model 
was constructed; however, we were unable to fit a parsimonious model because none of 
the covariates reached statistical significance (p<0.05). (Details in the Aim 2 Results 
section.) 
 
Time-to-Event (Survival) Analysis 
Time-to-event (survival) analysis refers to statistical procedures that analyze the time 
until a well-defined endpoint (event) occurs (Schober & Vetter, 2018). These specific 
analyses are required because of the unique features of time-to-event data. For example, 
not all individuals will experience the event of interest during the study observation 
period, resulting in unknown/incomplete observations for some individuals (called 
“censoring”), which must be resolved through the application of appropriate statistical 
techniques (Schober & Vetter, 2018). For our Aim 2 time-to-event analysis, we used Proc 
Lifetest in SAS to model the underlying survival distribution function of our time-to-event 
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data (Allison, 2010) and estimate the unadjusted time to diagnosis of depression (event) 
from the initial diagnosis of stroke (in days) by dysphagia severity groups. Then we 
compared Kaplan-Meier survival curves between dysphagia severity groups. 
 
Aim 3 Data Analysis 
For Aim 3, we calculated means and standard deviations for continuous variables and 
frequencies and proportions for categorical variables. We compared demographics and 
clinical characteristics for normally distributed data using t-tests for continuous variables 
and chi-square or Fisher’s exact for categorical variables. We used nonparametric 
Wilcoxon Rank Sum/Mann Whitney U and Kruskal-Wallis for non-normally distributed 
variables. For the cost analysis, we performed gamma-distributed generalized linear 
modeling with a log-transformed link function. To analyze cost by dysphagia severity 
clusters/groups, we applied the ADDSS, created in Aim 2, to this data set. 
 
Cost Analysis 
First, we graphically assessed the normality of the distributions of the cost data using 
histograms, and we also used the Shapiro-Wilk test (Shapiro & Wilk, 1965) to determine if 
the data were normally distributed. Next, we assessed for homoscedasticity via the White 
test (White, 1980), which tests for constant variance in a regression model. Once we 
confirmed the data were non-normally distributed and that heteroscedasticity was 
present, we applied generalized linear models (GLMs) to compare healthcare costs in 
post-stroke dysphagic patients with and without a diagnosis of depression. We used 
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gamma-distributed GLMs (Proc Genmod in SAS) with logarithmic transformation based 
on the right-skewed distribution and presence of heteroscedasticity in our cost data. 
GLMs with gamma distribution are known for being an appropriate statistical approach 
for analysis of cost data, which typically have a right-skewed distribution (Manning et al., 
2005). We chose the natural log transformation (log link) because it is known to stabilize 
variance (approximate homoscedasticity) and result in improve distribution symmetry in 
cost data (Blough & Ramsey, 2000). Next, in addition to our primary independent variable 
of interest (post-stroke depression [PSD]), we determined which clinically relevant 
covariates would be included in our initial models to control for potential population 
differences. We chose age, NIHSS score, CCI score, female gender, race (white, black, 
Hispanic, other), tPA administration, dual eligibility, and dysphagia severity cluster (mild, 
moderate, severe) as covariates to be included one at a time in each of our individual 
GLMs. We did not include discharge location (home, inpatient rehabilitation [IPR] facility, 
skilled nursing facility [SNF], transferred to another facility [from the acute hospital]) as a 
covariate in the models because this is an in-hospital designation that is endogenous to 
post-discharge cost values. Finally, covariates that were not significant at p<0.25 were 
manually removed one at a time, and the models were refit using the traditional level of 
statistical significance (p<0.05) until a parsimonious model was constructed. 
 
We determined the goodness of fit (GOF) of our final models via the deviance to degrees 
of freedom (DF) ratio, which posits that if the model is a good fit for the data, the 
deviance to DF ratio value will be close to one (UCLA: Statistical Consulting, n.d.-b). Our 
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gamma-distributed GLMs met this criterion; therefore, they were judged to have 






Aim 1 Results 
To determine the rate of PSD in patients with post-stroke dysphagia, we analyzed a data 
set of Medicare beneficiaries who had been diagnosed with AIS from the 2017 Medicare 
5% LDS. We used descriptive statistics to show trends in the data set and hypothesis 
testing to address our hypothesis: The rate of PSD in patients with post-stroke dysphagia 
is at least as high as the rate of PSD in the general stroke population. Our results 
supported our hypothesis. We found that the rate of PSD in post-stroke dysphagic 
patients is slightly higher than the rate in non-dysphagic patients. 
 
Patient Characteristics 
Our data set of 9,163 patients had a mean age of 78.66 years (SD 8.56) with a range of 
65-98 years. Fifty-three percent of patients were women and 82% were white, which is in 
line with the demographic makeup of the overall Medicare beneficiary population in 
which 54% are women and 75% are white (“Medicare Beneficiary,” 2017). (Patient 
characteristics and descriptive data are summarized in Table 1.) Of the patients in the 
general stroke population, 1,440 (15.72%) were diagnosed with dysphagia during their 
inpatient hospitalization. Compared to patients not diagnosed with dysphagia, those with 
 
 
a dysphagia diagnosis had higher CCI and SASI scores, though they were not significantly 
higher. Furthermore, there were no significant differences in age, gender, or race 
between patients diagnosed with dysphagia and patients not diagnosed with dysphagia. 
In contrast, those diagnosed with dysphagia demonstrated significantly higher rates of 
depression diagnosis than those not diagnosed with dysphagia during acute 
hospitalization, 12.01% versus 9.52%, respectively (p=0.003). Patients diagnosed with 
dysphagia also demonstrated greater incidence of cognitive decline (p <.0001) at 29.24% 
compared to 18.93% for patients not diagnosed with dysphagia. The mean LOS for 
patients with a dysphagia diagnosis was 7.99 days (SD 5.76, p<.0001), which on average 
was approximately three days longer than patients without a dysphagia diagnosis. Fewer 
patients diagnosed with dysphagia received tPA (3.47%) as compared to patients not 
diagnosed with dysphagia (5.31%, p=0.003). Those with a dysphagia diagnosis were also 












































































 N (%) N (%) N (%)  
Female 4901 (53.49) 780 (54.17) 4121 (53.36) 0.573 
Race    0.115 
     White 7532 (82.20) 1157 (80.35) 6375 (82.55) -- 
     Black 1042 (11.37) 171 (11.88) 871 (11.28) -- 
     Hispanic 132 (1.44) 25 (1.74) 107 (1.39) -- 
     Other 457 (4.99) 87 (6.04) 370 (4.79) -- 
Depression 908 (9.91) 173 (12.01) 735 (9.52) 0.003 
Cognitive decline 1883 (20.55) 421 (29.24) 1462 (18.93) <.0001 
tPA 460 (5.02) 50 (3.47) 410 (5.31) 0.003 
Dual eligibility 1616 (17.64) 292 (20.28) 1324 (17.14) 0.004 
Footnote: N=population size, SD=standard deviation, CCI=Charlson Comorbidity Index, 
SASI=Stroke Administrative Severity Index, tPA=tissue plasminogen activator, LOS=length 




Odds of PSD 
We used multivariable logistic regression to examine the relationship between PSD and 
post-stroke dysphagia. All predictor variables were included in the initial model (Table 2). 
After insignificant variables were manually removed and collinearity was verified, we ran 
the final parsimonious model (Table 3). The HL GOF test of a random 10% sample of the 
population (n=917) demonstrated that the model was a good fit with an insignificant p-
value >0.05 (p=0.7984). 
 
Table 2. Initial multivariable logistic regression model to determine association between 
PSD and post-stroke dysphagia with all potential covariates included.  
Variable Coefficient SE OR 95% CI p-value 
Post-stroke dysphagia  0.9904 0.0828 2.692 2.289-3.167 <.0001 
Age -0.2714 0.0441 0.762 0.699-0.831 <.0001 
Female  0.5438 0.0759 1.722 1.484-1.999 <.0001 
Racea  
  White  0.5722 0.1421 1.850 1.435-2.384 <.0001 
  Hispanic -0.7632 0.3858 0.487 0.174-1.358 0.048 
  Other  0.2339 0.1815 1.319 0.884-1.967 0.198 
CCI -0.00407 0.0172 0.996 0.963-1.030 0.813 
SASI -0.00876 0.00573 0.991 0.980-1.002 0.126 
tPA  0.2426 0.1546 1.275 0.941-1.726 0.117 
LOS  0.0145 0.00783 1.015 0.999-1.030 0.065 
Dual eligibility  0.3497 0.0917 1.419 1.185-1.698 0.0001 
Intercept -1.2083 0.3661 -- -- 0.001 
Footnote: SE=standard error, OR=odds ratio, CI=confidence interval, CCI=Charlson 
Comorbidity Index, SASI=Stroke Administrative Severity Index, tPA=Tissue plasminogen 




Table 3. Final multivariable logistic regression model with significant covariates included 
and Hosmer-Lemeshow Goodness-of-Fit test. 
Variable Coefficient SE OR 95% CI p-value 
Post-stroke dysphagia  0.9972 0.0804 2.711 2.315-3.174 <.0001 
Age -0.2714 0.0441 0.762 0.699-0.831 <.0001 
Female  0.5383 0.0757 1.713 1.477-1.987 <.0001 
Racea  
  White  0.5684 0.1419 1.818 1.413-2.340 <.0001 
  Hispanic -0.7677 0.3857 0.478 0.171-1.333 0.047 
  Other  0.2289 0.1814 1.295 0.868-1.931 0.207 
Dual eligibility  0.3553 0.0912 1.427 1.193-1.706 <.0001 
Intercept -1.1812 0.3587 -- -- 0.001 
 n Percent of 
population 
X2 DF p-value 
HLb 917 10 4.6094 8 0.7984 
Footnote: n=sample size, SE=standard error, OR=odds ratio, CI=confidence interval, 
X2=chi-square statistic, DF=degrees of freedom. aReference group was black patients. 
bHosmer-Lemeshow Goodness-of-Fit test applied to a 10% random sample of the 
population. 
 
We conducted multivariable logistic regression analysis on the entire population 
(N=9,163), which revealed that patients who were diagnosed with post-stroke dysphagia 
were 2.7 times more likely to be diagnosed with PSD within 90 days after discharge 
(adjusted OR, 2.711; 95% CI, 2.315-3.174; p<.0001) compared to patients who were not 
diagnosed with post-stroke dysphagia. White patients were 81.8% more likely to be 
diagnosed with PSD than black patients (adjusted OR, 1.818; 95% CI, 1.413-2.340; 
p<.0001). Furthermore, white patients were shown to be the only race significantly more 
likely to be diagnosed with depression after stroke. The odds of being diagnosed with 
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PSD increased in women by 71.3% (adjusted OR, 1.713; 95% CI, 1.477-1.987; p<.0001) 
and in individuals who qualified for dual eligibility by 42.7% (adjusted OR, 1.427; 95% CI, 
1.193-1.706; p<.0001). The odds of depression diagnosis decreased by 23.8% with age 
(adjusted OR, 0.762; 95% CI, 0.699-0.831; p<.0001). 
 
Unadjusted Time to Depression  
Without covariate adjustment, the unadjusted estimation of mean time from diagnosis of 
AIS to diagnosis of depression was 40 days (SD ± 30.69) for patients diagnosed with 
dysphagia and 34 days (SD ± 30.18) for patients not diagnosed with dysphagia (Table 1). 
Although patients who had a diagnosis of post-stroke dysphagia demonstrated greater 
mean days to depression diagnosis than patients who did not have a diagnosis of post-
stroke dysphagia, these results were not significant (p=0.729). The unadjusted survival 
plot (Figure 2) illustrated the differences in time to depression diagnosis between those 
who were diagnosed with dysphagia and those who were not diagnosed with dysphagia. 
It showed that both groups had an equally high probability of survival (not being 
diagnosed with PSD) soon after discharge, and as the 90-day post-discharge time period 
progressed, patients without a dysphagia diagnosis demonstrated better survivability 
(less likelihood of being diagnosed with depression) than patients with a dysphagia 
diagnosis. Furthermore, patients who were diagnosed with dysphagia appeared to 
experience a steady increase in diagnosis of PSD compared to those not diagnosed with 
dysphagia over the 90-day post-discharge time period, with the dysphagic group 
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demonstrating an approximately 1.5-fold higher probability of being diagnosed with PSD 
during the last 15 days of follow-up. 
 
 
Figure 2. Survival curve for PSD during 90-day post-discharge follow-up period by 
presence of dysphagia diagnosis, Kaplan-Meier method. 
 
Unadjusted initial Cox proportional hazards models were run on each covariate 
separately to determine potential influence on time to depression. We found a significant 
effect for dysphagia, age, gender (female), race (white), LOS, and dual eligibility. 
Unadjusted Cox models showed that the hazard for depression diagnosis in patients who 
have been diagnosed with post-stroke dysphagia was 2.4-fold greater (HR, 2.420; 95% CI, 
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2.099-2.790; p<.0001) than the hazard of depression diagnosis in those without a 
dysphagia diagnosis. Conversely, with each increase in year of age after discharge from 
the hospital, the hazard for diagnosis of PSD decreased by 1.5% (HR, 0.985; 95% CI, 
0.978- 0.993; p=0.0002). The hazard for women was approximately 54% (HR, 1.541; 95% 
CI, 1.345- 1.766; p<.0001) great than the hazard for men, while the hazard of depression 
diagnosis for white patients was 37% (HR, 1.37; 95% CI, 1.087- 1.727; p=0.0077) greater 
than the hazard for depression diagnosis for non-white patients. For each one-day 
increase in LOS, the hazard of PSD diagnosis increased by 2.2% (HR, 1.022; 95% CI, 1.010- 
1.034; p=0.0002). The hazard of PSD diagnosis for those who qualified for dual eligibility 
was about 41% (HR, 1.414; 95% CI, 1.210- 1.652; p<.0001) greater than the hazard for 
those who did not qualify for dual eligibility. No significant effects were observed for 
Hispanic or “other” race, CCI, SASI, or tPA. 
 
Adjusted Time to Depression  
Results from the extended Cox model with covariate adjustment (Table 4) were 
comparable to unadjusted results. Based on the model, having a diagnosis of dysphagia, 
being female, being white, and having dual eligibility significantly increased the risk of 
being diagnosed with depression after stroke, while every year of age significantly 
decreased the risk of depression diagnosis. The dysphagia-by-time interaction covariate 
that we incorporated into the extended Cox model allowed the effect of dysphagia (our 
covariate of greatest interest) to change with time (Allison, 2010), and its significance 
suggested that the dysphagia effect did, in fact, vary over time since discharge from the 
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hospital. This is illustrated by the adjusted cumulative hazard plot (Figure 3), which 
showed that when controlling for significant covariates, the hazard for diagnosis of PSD 
was initially low (<0.01) until about the tenth day after discharge and then consistently 
increased throughout the duration of the 90-day follow-up period for both patients with 
and without a diagnosis of post-stroke dysphagia. On average and on any given day in the 
90 days after discharge, the hazard for diagnosis of depression for patients who had a 
dysphagia diagnosis was approximately 76% greater (HR, 1.755; 95% CI, 1.368-2.251; 
p<.0001) than the hazard for patients who did not have a dysphagia diagnosis. In 
addition, the hazard of PSD diagnosis for women was about 67% higher than (HR, 1.666; 
95% CI, 1.449-1.915; p<.0001) the hazard for men, while the hazard of depression 
diagnosis for individuals with dual eligibility was approximately 40% higher than (HR, 
1.404; 95% CI, 1.193-1.654; p<.0001) the hazard for those who did not have dual 
eligibility. In contrast, hazard decreased significantly by 2.5% (HR, 0.975; 95% CI, 0.967-
0.982; p<.0001) with each year of age, suggesting that older stroke survivors are less 
likely to be diagnosed with depression. When controlling for significant covariates, we 
found that the hazard of PSD diagnosis for white patients was 71% higher than (HR, 
1.708; 95% CI, 1.401-2.082; p<.0001) the hazard for non-white patients, placing white 
patients at greater risk for diagnosis of depression than any other race. We ran additional 
Cox models to determine if there were any significant interaction effects between 
dysphagia and other significant covariates (age, gender (female), race (white), LOS, dual 




The adjusted cumulative hazard plot (Figure 3) showed that when controlling for 
significant covariates, there was a low immediate hazard for depression diagnosis 
followed by a steady increase in hazard for both groups, people with and without a 
diagnosis of dysphagia, over time, continuing until the end of the follow-up period. The 
group with a diagnosis of dysphagia demonstrated a higher hazard for depression 
diagnosis almost immediately after discharge and for the duration of the 90-day follow-
up period compared to the group without a diagnosis of dysphagia. Furthermore, those 
diagnosed with post-stroke dysphagia demonstrated an approximately 1.75-fold higher 
hazard for PSD diagnosis than those not diagnosed with post-stroke dysphagia, 
suggesting that at any given time in the 90 days after discharge, the hazard for 
depression diagnosis is higher for patients diagnosed with dysphagia compared to 
patients not diagnosed with dysphagia. 
 
Table 4. Final parsimonious Cox proportional hazards model with significant covariates. 
Variable Coefficient SE HR 95% CI p-value 
Post-stroke dysphagia 0.56246 0.56246 1.755 1.368-2.251 <.0001 
Female 0.51049 0.07109 1.666 1.449-1.915 <.0001 
Race, white 0.53525 0.10101 1.708 1.401-2.082 <.0001 
Dual eligibility 0.33958 0.08341 1.404 1.193-1.654 <.0001 
Age (years) -0.02581 0.00412 0.975 0.967-0.982 <.0001 





Figure 3. Hazard curve for PSD during 90-day post-discharge follow-up period by 




For Aim 2, we developed a novel proxy index of dysphagia severity for use with 
administrative data – ADDSS – to identify patients with similar dysphagia and stroke 
severity during acute hospitalization (hypothesis 1). Then we used the ADDSS to examine 
the proportion of, risk of, and time to depression diagnosis by dysphagia severity group 
after discharge (hypothesis 2).  Our results supported hypothesis 1 in that we created the 
ADDSS using a stable subset of ICD-10 dysphagia diagnosis and procedure codes to 
identify groups of patients with distinct dysphagia severity characteristics. Our results 
were not supportive of hypothesis 2, given that we did not find a statistically significant 
difference in risk of PSD diagnosis after discharge by dysphagia severity, nor did the 
evidence support our hypothesis 2 sub-hypotheses (2a, 2b, or 2c). 
 
Patient Characteristics 
In our NIHSS data set of 445 post-stroke patients with a diagnosis of dysphagia in the 
acute hospital, the mean age of the sample was 80 years (8.96) with a range of 65 to 98 
years (Table 5 for baseline characteristics and descriptive data of the population). Fifty-
five percent of patients were female and 83% were white, which is similar to the 
demographic makeup of the overall Medicare population in which 54% are female and 
75% are white (“Medicare Beneficiary,” 2017). On average, patients in this sample 
presented with moderate stroke severity, indicated by a mean NIHSS score of 11.46 
(8.25). The mean SASI score was 10.44 (6.92), or severe (Simpson et al., 2018), and the 




The mean LOS in this population was 7.88 days (5.17), which is slightly higher than the 
average six-day LOS among ischemic stroke patients (Koton et al., 2010) and lower than 
the average LOS of post-stroke dysphagic patients, considering that a diagnosis of 
dysphagia may result in almost five additional days in the acute hospital (Atrill et al., 
2018). In addition, the mean cost of the inpatient stay was $84,620 ($89,510). 
Approximately 5% of patients received tPA, 27% presented with cognitive decline, and 
13% were diagnosed with depression during inpatient hospitalization. The majority of 
patients were discharged from the acute hospital to a SNF (33%) or an IPR facility (30%), 
















Table 5. Baseline characteristics and descriptive data for Aim 2 
Stroke with Dysphagia, N=445 (100%) 






Female  243 (54.61) 
Race   
     White  371 (83.37) 
     Black  45 (10.11) 
     Hispanic  6 (1.35) 
     Other  23 (5.17) 
NIHSS 














LOS, days 7.88 (5.17) 
1-36 
 
Cost incurred $84,620 ($89,510) 
$7,196-$911,378 
 
tPA  22 (4.94) 
Cognitive decline  120 (26.97) 
Depression  59 (13.26) 
Dual eligibility  91 (20.45) 
Discharge location    
     Home  31 (6.97) 
     IPR  135 (30.34) 
     SNF  147 (33.03) 
     HH  36 (8.09) 
     Trans  13 (2.92) 
     Other  53 (11.91) 
Died in hospital  30 (6.74) 
Footnote: N=population size, SD=standard deviation, NIHSS=National Institutes of Health 
Stroke Scale, SASI=Stroke Administrative Severity Index, CCI=Charlson Comorbidity Index, 
LOS=length of stay, tPA=tissue plasminogen activator, IPR=inpatient rehabilitation, 




Hypothesis 1: Development of ADDSS 
Cluster Analysis 
Through the previously described procedure, we used K-means cluster analysis to group 
dysphagia-related variables into clusters to infer dysphagia severity. All variables 
(Appendix 4) were included in the initial algorithm (Table 6). Through a trial-and-error 
process during each iteration, we manually removed any variables that were judged to 
overwhelm the explanatory power of the other variables (high R-square value) and/or 
were not clinically meaningful and then re-ran the algorithm until the resulting statistics 
were considered optimal (Table 6). Based on the estimated criteria for the ideal number 
of clusters, we considered three clusters to be optimal for this data set. The three distinct 
clusters each characterized a disparate level of dysphagia severity (i.e., mild, moderate, 
or severe). The cluster means and distributions of variables across the three clusters are 
shown in Table 7.  
 
Table 6. K-means cluster analysis iterations and statistics 








1st 7 0.65 138.29 0.49 28.04 
2nd 6 0.59 124.49 0.47 18.07 
3rd 5 0.58 152.05 0.44 22.72 
4th 4 0.57 199.11 0.40 27.65 






Table 7. Cluster means by variable 
Variable Cluster 1 Cluster 2 Cluster 3 
Aspiration pneumonia 0.33 0.04 0.38 
Cognitive impairment 0.29  0.29 0.15 
Dehydration 0.06 0.04 0.05 
Feeding device placement 1.00 0 0.38 
Intubation 0.02 0.01 0.34 
Malnutrition 0.16 0.03 0.08 
Respiratory problems 0 0 0.98 
Tracheotomy/Tracheostomy 0 0 0.09 
 
Description of Clusters 
Clinical classifications of the clusters were assessed via the means of each of the eight 
variables (attributes) (Table 7) across clusters and graded into three qualitative 
categories. Cluster 1 showed evidence of dysphagia severity in the setting of alternative 
nutrition with the highest means for feeding device placement, malnutrition, and 
dehydration. Using feeding device placement as the primary marker of dysphagia severity 
and given that the mean for feeding device placement in Cluster 1 was 1.0 versus 0 and 
0.38 for Clusters 2 and 3, respectively, patients in Cluster 1 were judged to have severe 
dysphagia severity. Patients in this cluster also showed evidence of aspiration pneumonia 
and cognitive impairment and contained six out of eight (75%) of the total attributes 
(dysphagia indicator variables constructed from dysphagia-related ICD-10 diagnosis and 
procedure codes in the cluster analysis), suggesting that patients in this group had 
substantial stroke-related illness; therefore, patients in Cluster 1 were also judged to 
have moderate overall stroke severity. Thus, Cluster 1 represented moderate stroke with 
severe dysphagia severity with an emphasis on alternative nutrition.  
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Cluster 2 had the lowest means of all attributes, except cognitive impairment, which was 
the only notable attribute in this cluster. Cases in this group had little evidence of active 
feeding, nutrition, or respiratory problems; hence, patients in Cluster 2 had mild 
dysphagia severity (with more cases of cognitive impairment compared to feeding, 
nutrition, or respiratory problems). Cluster 2 also contained 63% of the total attributes, 
suggesting that (like patients in Cluster 1) patients in Cluster 2 had substantial stroke-
related illness and, as such, were determined to have had moderate overall stroke 
severity. Thus, Cluster 2 represented moderate stroke with mild dysphagia. 
 
Cluster 3 demonstrated evidence of dysphagia severity with more cases of respiratory 
compromise than any other clusters and the highest means for respiratory problems, 
aspiration pneumonia, intubation, and tracheotomy/tracheostomy. Because it is known 
that aspiration pneumonia is difficult to differentiate from other pneumonia types and, 
consequently, is often misdiagnosed (Son et al., 2017), feeding device placement, not 
aspiration pneumonia, was used as the most important (and reliable) marker for 
dysphagia severity. Additionally, intubation in this cluster was likely driven by diagnoses 
of respiratory conditions, not dysphagia severity; therefore, given that the mean for 
feeding device placement (0.38) was the second highest out of all of the clusters, we 
determined that patients in Cluster 3 had moderate dysphagia severity. Cluster 3 also 
contained 100% of the total attributes, indicating that patients in this cluster were very ill 
compared to those in the other clusters; therefore, these patients were judged to have 
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moderate/severe overall stroke severity. Thus, Cluster 3 represented moderate/severe 
stroke with moderate dysphagia severity with respiratory complications.  
 
Cluster Validation 
We conducted a subgroup sensitivity analysis by applying the three-cluster solution 
(algorithm) to three 60% random samples of the data set to assess cluster stability (Table 
8). We compared the cluster means of key outcomes that are indicators of stroke severity 
(NIHSS, LOS, and CCI) to their means from the initial cluster analysis and determined that, 
overall, they were stable and demonstrated a good fit. In the Mild dysphagia severity 
with moderate stroke cluster (Cluster 2), mean NIHSS scores were 10.08 in the initial 
100% sample and 10.67, 11.60, and 10.32, respectively, across 60% random samples, and 
in the Moderate dysphagia severity with moderate/severe stroke cluster (Cluster 3), 
NIHSS scores were 16.23 in the initial 100% sample and 15.52, 16.53, and 16.64, 
respectively, across the three 60% random samples. In the Severe dysphagia severity with 
moderate stroke cluster (Cluster 1), mean NIHSS scores were 13.51 in the initial 100% 
sample and 13.97, 12.69, and 11.12, respectively, across all three 60% random samples. 
The validation of cluster distribution for mean NIHSS score by severity showed very small 
differences in patient characteristics, indicating consistency and stability.  
 
In the Mild dysphagia severity with moderate stroke cluster (Cluster 2), mean CCI scores 
were 4.27 in the initial 100% sample and 4.21, 4.36, and 4.12, respectively, across 60% 
random samples. The mean CCI score in the initial 100% sample for the Moderate 
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dysphagia severity with moderate/severe stroke cluster (Cluster 3) was 5.11, and across 
the first, second, and third 60% random samples, mean CCI scores were 4.96, 4.76, and 
5.05, respectively. Mean CCI scores in the Severe dysphagia severity with moderate 
stroke cluster (Cluster 1) were 4.65 in the initial 100% sample, and in the first, second, 
and third 60% random samples, they were 5.08, 4.76, and 5.00, respectively. Mean CCI 
scores were very similar (close) across clusters and samples, demonstrating excellent 
consistency and stability.  
 
In the initial 100% sample for the Mild dysphagia severity with moderate stroke cluster 
(Cluster 2), mean LOS was 6.22 days, and across the 60% random samples, it was 6.32, 
6.58, and 7.42 days, respectively. For the Moderate dysphagia severity with 
moderate/severe stroke cluster (Cluster 3), in the initial 100% sample, mean LOS was 
10.51 days and 10.72, 12.41, and 10.43 days, respectively, across the 60% random 
samples. Mean LOS in the initial 100% sample for the Severe dysphagia severity with 
moderate stroke cluster (Cluster 1) was 13.52 days, and across the first, second, and third 
60% random samples, mean LOS was 12.74, 13.06, and 7.75 days, respectively. The 
cluster distribution for mean LOS demonstrated the greatest stability across all samples 
in the Mild dysphagia severity with moderate stroke cluster (Cluster 2), which comprised 
the largest proportions of the 100% and three 60% samples, respectively. The most 
notable disparities in mean LOS were observed in the third 60% random sample of the 
Severe dysphagia severity with moderate stroke cluster (Cluster 1) and the second 60% 
random sample of the Moderate dysphagia severity with moderate/severe stroke cluster 
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(Cluster 3), which could be explained by the small sample sizes in those clusters (n=74 
and n=16, respectively), yielding more unstable results (which is typical of means in small 
samples). In addition, mean LOS is known for being sensitive to outliers and, thus, could 
have been affected by unknown outliers not included in the original cluster analysis. 
Despite this, mean NIHSS scores demonstrated overall adequate stability. 
 
Table 8. Subgroup sensitivity analysis for cluster validation  
Clustera Variable Initial 100% 
sample (mean) 
1st 60% sample 
(mean) 
2nd 60% sample 
(mean) 
3rd 60% sample 
(mean) 
1 NIHSS 13.51 13.97 12.69 11.12 
CCI 4.65 5.08 4.76 5.00 
LOS 13.52 12.74 13.06 7.75 
% in cluster 14% 15% 18% 28% 
2 NIHSS 10.08 10.67 11.60 10.32 
CCI 4.27 4.21 4.36 4.12 
LOS 6.22 6.32 6.58 7.42 
% in cluster 71% 76% 75% 56% 
3 NIHSS 16.23 15.52 16.53 16.64 
CCI 5.11 4.96 4.76 5.05 
LOS 10.51 10.72 12.41 10.43 
% in cluster 15% 9% 6% 16% 
Footnote: NIHSS=National Institutes of Health Stroke Scale, LOS=length of stay, 
CCI=Charlson Comorbidity Index. Three-cluster algorithm applied to three separate 60% 
random samples of the data set.  
aCluster 1=severe dysphagia severity with moderate stroke; Cluster 2=mild dysphagia 
severity with mild stroke; Cluster 3=moderate dysphagia severity with severe stroke. 
 
Composition of Clusters 
The demographics and characteristics of patients in each cluster are shown in Table 9. 
The distributions of gender and race proportions in each cluster were similar to the 
distributions in the overall sample, with the Mild dysphagia severity cluster containing 
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the oldest group (mean, 80.66; SD, 9.06) and the Moderate dysphagia severity cluster 
containing the youngest group (mean, 77.62; SD, 8.37). We found statistically significant 
differences in age, NIHSS score, SASI score, LOS, acute hospital costs, dual eligibility, and 
discharge disposition among the three clusters. 
 
Mild Severity 
The Mild dysphagia severity cluster, which also represented patients with moderate 
stroke severity, comprised the largest proportion of patients (71%) out of all of the 
clusters and had patients with the lowest severity. This cluster consisted of 54% women. 
Although patients in the Mild cluster were the oldest, they had the lowest mean NIHSS 
score (10.08 ±7.93), SASI score (9.26 ±6.19), CCI score (4.27 ±2.26), and LOS (6.22 ±3.34) 
compared to patients in the other clusters. Furthermore, the Mild cluster had the second 
highest proportion of tPA administration (5%), highest proportion of patients who were 
discharged home (9%) and to IPR (32%), and lowest proportion of patients who died in 
the acute hospital (3%) compared to patients in the other clusters. They also incurred the 
lowest costs (mean, $59,571; SD, $53,326) compared to patients in the other clusters.  
 
Moderate Severity 
The Moderate dysphagia severity cluster, which represented patients with 
moderate/severe stroke severity, contained 15% of the sample and, overall, had patients 
with the greatest severity, indicated by stroke-related outcomes, such as the highest 
mean NIHSS, SASI, and CCI scores (16.23 ±8.18, 16 ±8.87, 5.11 ±2.24, respectively) and 
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highest costs (mean, $155,309; SD, $145,766) among all clusters. Similar to the other two 
clusters, about 55% of patients in this cluster were women. Patients in the Moderate 
dysphagia severity with moderate/severe stroke cluster had the lowest proportion of tPA 
administration (0%), highest proportion of patient mortality in the acute hospital (20%), 
and lowest proportion of patients to discharge home (0%). Patients in the Moderate 
dysphagia severity with moderate/severe stroke cluster stayed in the acute hospital 
(mean, 10.51; SD, 5.75) longer than patients in the Mild cluster on average but had a 
shorter mean LOS than those in the Severe dysphagia severity cluster. The majority of the 
patients in the Moderate dysphagia severity cluster discharged to IPR (30%) versus all 
other discharge locations. 
 
Severe Severity 
The Severe dysphagia severity cluster, which represented patients with moderate stroke 
severity, was comprised of 14% of the sample. Fifty-six percent of patients in this cluster 
were women, which is a similar proportion to the Mild and Moderate dysphagia severity 
clusters. Out of the three clusters, patients in the Severe dysphagia severity with 
moderate stroke cluster demonstrated mean NIHSS (13.51 ±7.78), SASI (10.63 ±5.12), 
and CCI scores (4.65 ±2.38) that were higher than patients in the Mild dysphagia severity 
with moderate stroke cluster but lower than patients in the Moderate dysphagia severity 
with moderate/severe stroke cluster. Similarly, the proportion of patients who died in the 
acute hospital (10%) in the Severe dysphagia severity with moderate stroke cluster was 
higher than that of patients in the Mild dysphagia severity cluster but lower than those in 
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the Moderate dysphagia severity cluster. Patients in the Severe dysphagia severity cluster 
also had the longest mean LOS (13.52 ±6.82) and greatest proportion of patients who 
were discharged to SNF (56%). Their hospital costs (mean, $137,728; SD, $98,165) were 
higher than costs incurred by patients in the Mild dysphagia severity with moderate 
stroke cluster but lower than those in the Moderate dysphagia severity with 
moderate/severe stroke cluster. Surprisingly, they had the highest proportion of tPA 















Table 9. Demographic and characteristic composition of clusters  






























































































 n (%) n (%) n (%)  
Female 172 (54.26) 36 (55.38) 35 (55.56) 0.7548 
Race    0.7082 
     White 270 (85.17) 53 (81.54) 48 (76.19) -- 
     Black 30 (9.46) 7 (10.77) 8 (12.70) -- 
     Hispanic 4 (1.26) 0 (0) 2 (3.17) -- 
     Other 13 (4.10) 5 (7.69) 5 (7.94) -- 
tPA 17 (5.36) 0 (0) 5 (7.94) 0.1246 
Depression 45 (14.20) 10 (15.38) 4 (6.35) 0.2847 
Dual eligibility 56 (17.67) 20 (30.77) 15 (23.81) 0.0144 
Discharge 
disposition  
   <.0001 
     Home 30 (9.46) 0 (0) 1 (1.59) -- 
     IPR 102 (32.18) 19 (29.23) 14 (22.22) -- 
     SNF 98 (30.91) 14 (21.54) 35 (55.56) -- 
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     HH 34 (10.73) 1 (1.54) 1 (1.59) -- 
     Trans 5 (1.58) 8 (12.31) 0 (0) -- 
     Other 37 (11.67) 10 (15.38) 6 (9.52) -- 
     Died in hospital 11 (3.47) 13 (20.00) 6 (9.52) -- 
Footnote: N=population size, n=sample size, SD=standard deviation, NIHSS=National 
Institutes of Health Stroke Scale, SASI=Stroke Administrative Severity Index, CCI=Charlson 
Comorbidity Index, LOS=length of stay, tPA=tissue plasminogen activator, IPR=inpatient 
rehabilitation, SNF=skilled nursing facility, HH=home health, Trans=transferred to 
another facility  
aMild dysphagia severity with moderate stroke; Moderate dysphagia severity with 
moderate/severe stroke; Severe dysphagia severity with moderate stroke. 
 
Hypothesis 2: Application of ADDSS 
Proportion of PSD Diagnosis After Discharge by Dysphagia Severity 
We applied the ADDSS to our post-discharge sample. Then we calculated frequencies and 
proportions of dysphagic patients with a diagnosis of PSD, stratified by dysphagia severity 
cluster, and used the chi-square test to determine statistical significance. We found that 
the proportions of PSD diagnosis across all three dysphagia severity groups were very 
similar (17%, 14%, and 16%, p=0.9016, respectively), revealing no statistically significant 
difference in proportions of PSD diagnosis in the 90 days after discharge by dysphagia 









Table 10. Proportion of and time to PSD diagnosis by dysphagia severity 
























n=51 (14%) p-value 
 n (%) n (%) n (%)  
Depression  45 (16.92) 6 (14.29) 8 (15.69) 0.9016 

















Footnote: N=population size, n=sample size, SD=standard deviation 
aMild dysphagia severity with moderate stroke; Moderate dysphagia severity with 
moderate/severe stroke; Severe dysphagia severity with moderate stroke. 
 
Risk of PSD Diagnosis After Discharge by Dysphagia Severity 
We performed multivariable logistic regression to (1) examine the relationship between 
PSD and post-stroke dysphagia by dysphagia severity levels and (2) test hypothesis 2b to 
determine if post-stroke patients with more severe dysphagia had greater risk of being 
diagnosed with PSD within the 90 days after discharge. In addition to our primary 
independent variable of interest, PSD, we included key predictor covariates, including 
dysphagia severity (by ADDSS clusters), age, CCI score, and dual eligibility, in our initial 
individual logistic regression models; however, we found none of the covariates to be 
statistically significant. Thus, no significant effect was found between dysphagia severity 
and risk of PSD diagnosis in the 90 days after discharge. Nonetheless, we observed that 
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compared to patients in the mild dysphagia cluster, those in the moderate and severe 
dysphagia severity groups were less likely to be diagnosed with PSD after discharge, but 
these results did not reach statistical significance. Thus, the evidence was not supportive 
of hypothesis 2b. 
 
Time to PSD Diagnosis After Discharge by Dysphagia Severity 
The unadjusted estimated mean time from diagnosis of AIS to diagnosis of depression 
was 39 days (SD ±39.00) for patients with mild dysphagia, 63 days (SD ±71.50) for 
patients with moderate dysphagia, and 70 days (SD ±73.50) for patients with severe 
dysphagia (Table 10). These results were statistically significant (p=0.0218) and 
demonstrated that those with mild dysphagia had the shortest mean time to PSD 
diagnosis within the 90-day period after discharge compared to patients in the other 
severity groups. Patients who had moderate dysphagia were diagnosed with depression, 
on average, sometime in between those in the mild and severe dysphagia severity 
groups, and those with severe dysphagia demonstrated the longest mean time to PSD 
diagnosis.  
 
We created a dichotomous variable for dysphagia severity: “mild” (patients classified as 
having mild dysphagia severity) and “not mild” (patients classified as having moderate or 
severe dysphagia severity) and performed a time-to-event (survival) analysis to generate 
an unadjusted survival plot (Figure 4). The survival plot illustrates the differences in time 
to depression diagnosis between patients with mild dysphagia and patients with 
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moderate and severe dysphagia. Patients in both groups had an equally high probability 
of not being diagnosed with PSD soon after discharge, with the likelihood of being 
diagnosed with depression steadily increasing in both groups as the 90-day post-
discharge period progressed (shown as descending survival curves in Figure 4). The 
median time to depression was 39 days (IQR, 44) for patients in the mild dysphagia 
severity group and 72.5 days (IQR, 48) for patients in the moderate or severe dysphagia 
severity group (p=0.0124). This means that 50% of patients with mild dysphagia had a 
diagnosis of depression a little more than one month after discharge, while 50% of 
patients with moderate or severe dysphagia had a diagnosis of depression almost at the 
end of the 90-day post-discharge follow-up period. Overall, patients with mild dysphagia 
demonstrated a greater likelihood of being diagnosed with depression in the 90 days 
after discharge compared to patients with moderate or severe dysphagia severity. These 
findings were not supportive of hypothesis 2c in which we hypothesized that patients 
with more severe dysphagia would have a shorter time to first depression diagnosis after 




Figure 4. Survival curves for PSD during 90-day post-discharge follow-up period by 




To determine if dysphagic patients with a PSD diagnosis incurred greater healthcare costs 
than dysphagic patients without a PSD diagnosis, we performed a cost analysis on a data 
set of post-discharge Medicare beneficiaries with a primary diagnosis of AIS who had 
been diagnosed with dysphagia during their inpatient acute hospitalization. We found 
that our results supported our hypothesis that patients who were diagnosed with 
dysphagia and PSD did, in fact, incur higher healthcare costs in the 90 days after 
discharge than those diagnosed with dysphagia alone. 
 
Patient Characteristics 
Our data set of 359 post-stroke patients diagnosed with dysphagia was stratified by 
dysphagia severity cluster according to the ADDSS (Table 11). There were no significant 
differences in gender or race among patients in all three dysphagia severity groups. The 
group with Mild dysphagia severity (and moderate stroke) contained 74% of the sample 
and had a mean age of 80.15 years (SD 8.94) with a range of 65-98 years. Patients in the 
Mild dysphagia cluster also had the lowest statistically significant mean NIHSS (8.53 
±6.87, p<.0001), SASI (9.16 ±6.34, p<.0001), and CCI (4.18 ±2.12, p=0.0276) scores; mean 
LOS (6.20 ±3.16, p<.0001); and proportion of dual eligibility (16%, p=0.0144) compared to 
those in the Moderate and Severe dysphagia clusters. Patients in the Mild group had the 
second highest proportion of tPA administration (6%, p=0.1306), lowest proportion of 
feeding tube placement (0%, p<.0001), and while they also had the highest proportion of 




(p=0.3894). Those in the Mild cluster were discharged home (23%, p<.0001) more than 
patients in the higher severity clusters, and the proportions discharged to IPR and SNF 
(37% and 38%, p<.0001, respectively) were in-between those in the Moderate and 
Severe dysphagia clusters.  
 
The Moderate dysphagia severity (with moderate/severe stroke) group contained 12% of 
the sample and had the youngest patients, with a mean age of 76.43 years (SD 8.09) and 
a range of 65-98 years. Patients in the Moderate dysphagia cluster had the highest mean 
NIHSS (16.02 ±7.47, p<.0001), SASI (14.67 ±7.45, p<.0001), and CCI (4.86 ±1.83, 
p=0.0276) scores of all the clusters. The mean LOS (11.52 ±5.84, p<.0001) was higher in 
the Moderate dysphagia group than in the Mild group and lower than the Severe group. 
Patients in the Moderate dysphagia group received the lowest proportion of tPA 
administration (0%, p=0.1306), though not statistically significant, and they also had the 
lowest proportion of discharge home (2%, p<.0001) and the highest discharge to IPR 
(45%, p<.0001). Twelve percent of patients in this group received a depression diagnosis 
after discharge, which was in-between those in the Mild and Severe dysphagia clusters; 
however, this finding was not statistically significant. Half of all patients in the Moderate 
dysphagia group had feeding tube placement (p<.0001), which was in-between the 
proportions for the Mild and Severe groups.    
 
The Severe dysphagia (with moderate stroke) group contained 14% of the sample and 
had a mean age of 78.57 years (SD 8.22) with a range of 65-95 years. Patients in the 
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Severe dysphagia cluster had mean NIHSS (12.53 ±7.99, p<.0001), SASI (10.69 ±5.57, 
p<.0001), and CCI (4.41 ±2.20, p=0.0276) scores that were in-between those of patients 
in the Mild and Moderate dysphagia clusters. Patients in the Severe dysphagia cluster 
also had the longest mean LOS (13.57 ±3.16, p<.0001) and the greatest proportion of 
patients who discharged to SNF (69%, p<.0001) compared to those in the Mild and 
Moderate clusters. They also had the lowest proportion of depression diagnosis after 
discharge (10%); however, this finding was not statistically significant. Patients in the 















Table 11. Baseline characteristics and descriptive data for Aim 3 









































































 n (%) n (%) n (%)  
Female 142 (53.38) 22 (52.38) 30 (58.82) 0.7548 
Race    0.3361 
     White 223 (83.83) 35 (83.33) 39 (76.47) -- 
     Black 29 (10.90) 5 (11.90) 7 (13.73) -- 
     Hispanic 2 (0.75) 0 (0) 1 (1.96) -- 
     Other 12 (4.51) 2 (4.76) 4 (7.84) -- 
Depression 44 (16.54) 5 (11.90) 5 (9.80) 0.3894 
Feeding tube 0 (0) 21 (50) 51 (100) <.0001 
tPA 16 (6.02) 0 (0) 5 (9.80) 0.1306 
Dual eligibility 43 (16.17) 13 (30.95) 15 (29.41) 0.0144 
Discharge location     <.0001 
     Home 61 (22.93) 1 (2.38) 2 (3.92) -- 
     IPR 99 (37.22) 19 (45.24) 14 (27.45) -- 
     SNF 100 (37.59) 14 (33.33) 35 (68.63) -- 
     Trans 6 (2.26) 8 (19.05) 0 (0) -- 
Footnote: N=population size; n=sample size, SD=standard deviation, NIHSS=National 
Institutes of Health Stroke Scale, SASI=Stroke Administrative Severity Index, CCI=Charlson 
Comorbidity Index, LOS=length of stay, tPA=tissue plasminogen activator, IPR=inpatient 
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rehabilitation, SNF=skilled nursing facility, HH=home health, Trans=transferred to 
another facility 
aMild dysphagia severity with moderate stroke; Moderate dysphagia severity with 
moderate/severe stroke; Severe dysphagia severity with moderate stroke. 
 
Cost of Care 
Unadjusted Cost  
Using univariate analysis to examine total 90-day post-discharge cost, we found that, on 
average, dysphagic patients (irrespective of severity) with a depression diagnosis had 
$12,667 higher mean total costs after discharge than those without depression, these 
results are statistically significant, p<.0001 (Table 12). When comparing the fully adjusted 
cost estimate from the multivariable model, there is some overlap in the 95% confidence 
intervals (CIs) which is not surprising given the small sample size used for this estimate. 
The mean unadjusted total 90-day post-discharge costs by dysphagia severity clusters 
show that patients with Mild and Severe dysphagia with a depression diagnosis had 
higher mean total costs ($15,914 and $11,680, respectively) than those without a 
depression diagnosis in the same dysphagia severity groups, while patients with 
Moderate dysphagia with a depression diagnosis had $316 lower mean total costs 
compared to those with Moderate dysphagia without a depression diagnosis (Table 12).  
 
We also found that patients in the Moderate dysphagia group (with moderate/severe 
stroke severity) had statistically significant unadjusted higher mean inpatient costs after 
discharge than those with Mild or Severe dysphagia severity (Figure 5 and Appendix 5). 
Patients with Moderate dysphagia had more inpatient rehabilitation admissions and/or 
 77 
 
readmissions to the acute hospital after discharge than those with more or less severe 
dysphagia (and less severe stroke severity). These results are consistent with the medical 
characteristics of the patients in the Moderate dysphagia group, in that they 
demonstrated the highest stroke severity, likely resulting in greater impairment and 
disability and requiring more intensive rehabilitation, which is why they also had the 
largest proportion of discharge to IPR facilities. Furthermore, patients in the Moderate 
dysphagia group were the most ill and had the most serious respiratory comorbidities, 
such as aspiration pneumonia, intubation, and tracheotomy/tracheostomy, out of all 
groups; thus, readmissions to the acute hospital are expected in this group. In contrast, 
we found that those with the least dysphagia severity (Mild) were overwhelmingly 
discharged home (23%) compared to patients with Moderate (2%) and Severe (4%) 
dysphagia severity, respectively (Table 11), and, as expected, patients discharged home 
had the lowest unadjusted mean total 90-day post-discharge costs, inpatient costs, and 










Table 12. Estimated mean total 90-day post-discharge costs and 95% confidence intervals 
for patients with and without depression diagnosis by overall dysphagia and dysphagia 
severity clusters 



































Depression     
























Footnote: N=population size, n=sample size, SD=standard deviation, CI=confidence 
interval 
aMild dysphagia severity with moderate stroke; Moderate dysphagia severity with 
moderate/severe stroke; Severe dysphagia severity with moderate stroke. 
bCost in United States dollars (USD).  
cColumn values are unadjusted  









We used multivariable analysis via gamma-distributed GLMs with logarithmic 
transformation to compare healthcare costs across dysphagia severity groups, with our 
main independent variable being PSD diagnosis. We included clinically relevant predictor 
variables in each of our initial individual models to determine if they were statistically 







Table 13. Regression parameters for 90-day post-discharge cost for each univariable 










Footnote: NIHSS=National Institutes of Health Stroke Scale, CCI=Charlson Comorbidity 
Index, tPA=tissue plasminogen activator, Reference=reference group in the model 
 
Controlling for the statistically significant covariates from our initial models, we fit our 
final parsimonious cost model measuring the effect of PSD on total 90-day post-discharge 
cost (Table 14). The results showed that a diagnosis of PSD was associated with increased 
mean total healthcare costs in the 90 days following discharge from the acute hospital. It 
also showed that stroke severity (NIHSS score) and dysphagia severity (moderate) 
significantly contributed to the variations in cost. This is illustrated in the increase in 
marginal cost difference between dysphagic patients with and without a diagnosis of 
Variable Parameter Estimate p-value 
Depression 0.3340 0.0201 
Dysphagia severity  0.0002 
     Mild    Reference -- 
     Moderate 0.6031 -- 
     Severe 0.2447 -- 
Age -0.0124 0.0442 
NIHSS 0.0278 <.0001 
Female 0.0102 0.9214 
CCI 0.0252 0.3399 
tPA -0.0920 0.6761 
Dual eligibility 0.1921 0.1377 
Race  0.6490 
     White -0.2014 0.2160 
     Black Reference -- 
     Hispanic -0.1716 0.7690 
     Other -0.1287 0.6413 
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depression, for which the unadjusted difference was $12,667 and now, controlling for 
dysphagia severity and stroke severity, the cost difference has increased to $15,556. 
 
Table 14. Estimated mean 90-day post discharge cost for patients with and without 
depression, controlling for effects of differences in dysphagia severity and stroke severity 
Footnote: SE=standard error, CI=confidence interval, NIHSS=National Institutes of Health 
Stroke Scale, Reference=reference group in the model 
 
In order to estimate the adjusted mean costs for the dysphagia severity groups with and 
without PSD, we created a variable that represented dysphagia severity by cluster (mild, 
moderate, or severe) in the presence or absence of PSD (“Mild/No PSD,” “Mild/PSD,” 
“Mod/No PSD,” “Mod/PSD,” “Sev/No PSD,” “Sev/PSD”). The “combination” independent 
variable was then used in a multivariable cost estimation model to measure the effect of 
PSD and dysphagia severity on total 90-day post-discharge cost. The results showed that 
having a PSD diagnosis and being in the mild dysphagia severity cluster were associated 
with higher 90-day costs (p=0.0089) (Table 15). We also found that stroke severity had a 
Variable 
Parameter 
Estimate SE 95% CI p-value 
Depression     
     Yes 0.3599 0.1419 0.0819 – 0.6379 0.0112 
     No  Reference -- -- -- 
Dysphagia severity     
     Mild    Reference -- -- -- 
     Moderate 0.5108 0.1687 0.1801 – 0.8414 0.0025 
     Severe 0.2243 0.1475 -0.0647 – 0.5134 0.1282 
NIHSS 0.0167 0.0074 0.0021 – 0.0312 0.0246 
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significant effect on cost (p=0.0259). The marginal cost difference was $15,914 higher for 
patients with Mild dysphagia severity with a diagnosis of depression compared to 
patients with Mild dysphagia severity without a diagnosis of depression, controlling for 
stroke severity. This finding supports our hypothesis that dysphagic patients with PSD will 
incur greater healthcare costs than dysphagic patients without PSD.  
 
Table 15. Estimated mean 90-day post discharge cost for patients in three different 
dysphagia severity groups with and without depression, controlling for effects of 
differences in stroke severity 
Footnote: SE=standard error, CI=confidence interval, NIHSS=National Institutes of Health 
Stroke Scale, PSD=post-stroke depression, Reference=reference group in the model 
 
To contrast cost differences between patients with mild dysphagia and those with 
moderate or severe dysphagia, we constructed a dichotomous variable for dysphagia 
severity – “mild” (patients classified as having mild dysphagia severity) or “not mild” 
(patients classified as having moderate or severe dysphagia severity). This approach 
Variable 
Parameter 
Estimate SE 95% CI p-value 
Dysphagia severity & PSD     
     Mild/No PSD    Reference -- -- -- 
     Mild/PSD    0.4119 0.1575 0.1032 – 0.7206 0.0089 
     Moderate/No PSD 0.5604 0.1786 0.2105 – 0.9104 0.0017 
     Moderate/PSD 0.5228 0.4342 -0.3282 – 1.3737 0.2286 
     Severe/No PSD 0.2427 0.1556 -0.0623 – 0.5478 0.1189 
     Severe/PSD 0.5049 0.4289 -0.3356 – 1.3455 0.2390 
NIHSS 0.0165 0.0074 0.0020 – 0.0311 0.0259 
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helped create more proportionate sample sizes per cluster (n=266 and n=93, 
respectively), which is helpful to understand the effect of small cluster samples on the 
variation in the adjusted cost estimates. Multivariable analysis results from this model 
(Table 16) were very similar to results from our other models (Tables 14 and 15) in that 
depression had a significant effect on cost, as did dysphagia severity (in this case, 
moderate or severe) and stroke severity (Figure 6), with a marginal cost difference 
between dysphagic patients with and without a diagnosis of depression of $10,745, 
controlling for dysphagia severity and stroke severity. 
 
Table 16. Estimated mean 90-day post discharge cost for patients with and without 
depression, controlling for effects of differences in dysphagia severity (by dichotomous 
dysphagia severity variable) and stroke severity 
Footnote: SE=standard error, CI=confidence interval, NIHSS=National Institutes of Health 
Stroke Scale, Not mild= patients classified as having moderate or severe dysphagia 




Estimate SE 95% CI p-value 
Depression     
     Yes 0.3541 0.1421 0.0755 – 0.6327 0.0127 
     No  Reference -- -- -- 
Dysphagia severity     
     Mild  Reference -- -- -- 
     Not mild    0.3530 0.1229 0.1122 – 0.5938 0.0041 




Figure 6. Effect of depression on 90-day post-discharge cost by mild dysphagia severity 
vs. moderate or severe dysphagia severity. 
 
Overall, results from this cost analysis consistently showed that not only does depression 
diagnosis significantly increase healthcare costs in the 90 days after discharge, so do 
stroke severity and dysphagia severity. We found that patients with dysphagia and 
depression (regardless of dysphagia severity) incur higher healthcare costs in the 90 days 
after discharge than dysphagic patients without depression, an unadjusted effect size of 
$12,667. Furthermore, we found that the presence of depression resulted in a 36% 
increase (β, 0.3599; 95% CI, 0.0819-0.6379; p=0.0112) in cost after controlling for 
dysphagia severity and stroke severity (adjusted effect size). We also found that 
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dysphagia severity cluster is an important covariate in explaining variations in post-
discharge cost for patients diagnosed with both post-stroke dysphagia and PSD, which is 
supportive of our Aim 2 Hypothesis 1 (i.e., development of the ADDSS) – that these 
dysphagia severity clusters are useful and clinically meaningful predictors in 





Aim 1 Discussion  
Section 1: Brief Summary of Results 
Objectives 
The objectives for Aim 1 were to not only examine the rate of diagnosis of PSD in patients 
with a diagnosis of post-stroke dysphagia but also to determine if it is at least as high as 
the rate of diagnosis of PSD in the general stroke population. Furthermore, we studied 
the relationship between PSD and post-stroke dysphagia, evaluated the odds and hazard 
of being diagnosed with depression after stroke, and estimated the time to depression 
from the initial stroke diagnosis in patients with and without a diagnosis of dysphagia. 
 
Hypothesis and Results 
Consistent with our hypothesis, the results from Aim 1 demonstrated that the rate of 
diagnosis of PSD in patients with a diagnosis of post-stroke dysphagia is at least as high as 
the rate of diagnosis of PSD in the general stroke population. In fact, patients diagnosed 
with dysphagia demonstrated slightly higher proportions of depression diagnosis during 
acute hospitalization (12%) compared to patients not diagnosed with dysphagia 
(approximately 10%). We also found that PSD diagnosis was significantly affected by 
 
 
dysphagia diagnosis during the 90-day post-discharge follow-up period as well, with 
those who had been diagnosed with dysphagia being almost three times more likely to be 
diagnosed with depression than patients who had not been diagnosed with dysphagia 
and the patients diagnosed with dysphagia demonstrating an approximately 1.75-fold 
higher hazard for PSD diagnosis than the patients not diagnosed with dysphagia. The 
mean time from stroke to depression diagnosis was higher for patients diagnosed with 
dysphagia compared to those not diagnosed with dysphagia (40 days versus 34 days, 
respectively), signifying that patients with a dysphagia diagnosis were diagnosed with 
depression later than patients without a dysphagia diagnosis; however, these results 
were not significant. Additional results are discussed in detail in the following sections. 
 
Section 2: PSD in Patients with Post-Stroke Dysphagia 
Related Research 
Dysphagia is a common consequence of stroke (Dziewas, et al., 2017; Gonzalez-
Fernandez et al., 2013; Labeit et al., 2018; Martino et al., 2005; Rofes et al., 2011, 2013), 
as is depression (Broomfield et al., 2014; Gillen et al., 1999; Saxena et al., 2007; Stein et 
al., 2020; Towfighi et al., 2017; Williams, 2005). It is believed that dysphagia has a 
substantial effect on mental health and is linked to depression (Dziewas, et al., 2017; 
Holland, 2011; Verdonschot et al., 2013, 2017); however, the incidence of PSD in post-
stroke dysphagic patients is not known. To our knowledge, there is no literature that 
specifically examines PSD in post-stroke dysphagic patients as a primary outcome. There 




al., 2011; Kang et al., 2012; Harris et al., 2017; Saxena et al., 2008); however, establishing 
rates of PSD in dysphagic patients and elucidating the relationship between PSD and 
post-stroke dysphagia were not the main objectives in these studies. For example, Kang 
et al. (2012) examined the effects of a dysphagia exercise program on swallow function 
and its indirect effect on depressive symptoms in subacute stroke patients with 
dysphagia (onset of stroke within six months) in a rehabilitation hospital. Although PSD 
was not their primary outcome of interest, the researchers reported that post-stroke 
dysphagic patients in both the control and experimental groups had severe (score of >29) 
mean Beck Depression Inventory (BDI) (Beck & Steer, 1993) scores before dysphagia 
treatment (Kang et al., 2012; Smarr & Keefer, 2011). After two months of treatment, the 
control group’s mean BDI scores remained severe (score of >29), and the mean BDI 
scores of the experimental group, who demonstrated significant improvement in (oral 
phase) swallow function, significantly decreased to scores in the moderate range (score 
of 20-28) (Kang et al., 2012; Smarr & Keefer, 2011). While improvement in mean BDI 
scores was observed in the experimental group, patients continued to experience 
moderate depressive symptoms, which could be due to the fact that their swallow 
function improvement (in oral phase only), though statistically significant, was not 
clinically meaningful (Kang et al., 2012). The researchers noted that there was no 
meaningful difference in proportions of patients with aspiration pneumonia or 
transitioning from tube feeding to oral feeding between groups (Kang et al., 2012); 
therefore, it is feasible that patients who continued to have pharyngeal phase dysphagia, 
particularly severe enough to result in aspiration pneumonia and/or the need for non-
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oral nutrition (tube feeding), would also continue to experience depressive symptoms. 
Harris et al. (2017) examined the prevalence of PSD and its association with functional 
status among African American stroke survivors in an inpatient rehabilitation setting. 
Although the researchers did not primarily study dysphagia in this patient population, 
they reported that individuals with depression had a significantly higher proportion of 
dysphagia compared to those without depression (60% versus 44.1%, p=0.014), 
suggesting that dysphagia is more common in those with depression during the subacute 
stroke period (Harris et al., 2017).  
 
Incidence of PSD Diagnosis 
One of the main findings in the present study was that patients diagnosed with post-
stroke dysphagia are at least as likely as those not diagnosed with post-stroke dysphagia 
to be diagnosed with PSD. There is a slightly higher proportion of PSD diagnosis in 
patients who had been diagnosed with post-stroke dysphagia compared to those who 
had not, 12% versus about 10%, respectively; however, the difference in proportions as 
well as the actual proportions of post-stroke dysphagia and PSD were much lower than 
expected, considering the substantially higher incidence of both diagnoses reported in 
the literature. Notwithstanding, our findings coincide with Harris et al.’s (2017) results 
(but with our proportions much lower than theirs). There are no other studies for direct 
comparison; however, our findings are still lower than expected if compared to studies 
that have reported incidence of PSD and post-stroke dysphagia separately. For example, 
our results showed that 10% of the general stroke population were diagnosed with 
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depression during acute hospitalization, which is substantially lower than the 
approximately 33% of stroke survivors who are reportedly diagnosed with depression at 
any one time after stroke (Hackett & Pickles, 2014; Kutlubaev & Hackett, 2014; Towfighi 
et al., 2017; Zhang et al., 2020). Similarly, our results demonstrated that 16% of the 
general stroke population had a diagnosis of dysphagia, which is remarkably low 
compared to Martino et al.’s (2005) systematic review report of 37-80% of stroke 
survivors experiencing dysphagia (depending on type of dysphagia screen and/or 
assessment used, timing of assessment after stroke, and lesion location). 
 
Section 3: The Problem of Underdiagnosis and Undercoding 
Underdiagnosis and Undercoding of Dysphagia 
We found that 16% of post-stroke patients have dysphagia in the acute hospital setting. 
The difference in our findings compared to those in the literature can be primarily 
explained by underdiagnosis and undercoding (Cohen et al., 2020; Dziewas, et al., 2017; 
Gonzalez-Fernandez et al., 2008; Labeit et al., 2018; Rofes et al., 2011; Takizawa et al., 
2016). Despite its high prevalence, post-stroke dysphagia is frequently underdiagnosed 
because of a number of factors, including restricted availability of dysphagia experts 
(speech-language pathologists [SLPs]) in hospitals, limited access to costly instrumental 
diagnostic equipment or other material resources in certain medical settings, and lack of 
consensus for which patients require dysphagia screening (Dziewas, et al., 2017; Labeit et 
al., 2018; Rofes et al., 2011). Furthermore, various methods for dysphagia evaluation are 
reported in studies examining post-stroke dysphagia, including patient report, screening 
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tools, bedside swallow assessment, and modified barium swallow study – all with varying 
levels of sensitivity for detecting dysphagia (Takizawa et al., 2016); therefore, depending 
on the evaluation method used, dysphagia may be missed in some stroke patients. For 
example, silent aspiration can occur in up to 67% of post-stroke patients with dysphagia 
(Daniels et al., 1998; Martino et al., 2012), and if the diagnostic tool to evaluate 
dysphagia does not have adequate sensitivity to detect silent aspiration (like patient 
report, screening tools, or bedside swallow assessments), then a potentially large 
proportion of individuals with dysphagia will go undiagnosed. In addition, underdiagnosis 
and undercoding of dysphagia are known limitations in administrative data analysis 
(Cohen et al., 2020; Gonzalez-Fernandez et al., 2008; Takizawa et al., 2016). 
Nevertheless, there is high specificity in dysphagia diagnosis within medical billing data; 
therefore, we can confidently assume that the patients who are diagnosed with 
dysphagia do, in fact, have dysphagia (Cohen et al., 2020). Conversely, we cannot assume 
that just because a patient does not have a diagnosis of dysphagia that dysphagia is not 
present; therefore, interpretations of the findings from this study should be made with 
caution. 
 
Underdiagnosis and Undercoding of PSD 
Correspondingly, PSD is an often underestimated and underdiagnosed sequela of stroke 
(Dar et al., 2017). It is underdiagnosed for a variety of reasons, including difficulties 
evaluating depression in patients with cognitive and/or language disorders (which are 
common after stroke), misattributing common symptoms of stroke and depression (such 
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as fatigue, poor sleep, and emotional lability) resulting in misclassification by healthcare 
providers, and use of screening tools with inadequate sensitivity for detecting depression 
(Conroy et al., 2020; Starkstein & Robinson, 1989; Williams, 2005). In addition, patients 
may not report depressive symptoms because of the social stigma associated with 
mental health disorders (Alaghehbandan & MacDonald, 2013). Due to the risk of 
mortality and number of serious co-occurring conditions that may present after stroke, it 
is feasible that healthcare providers in the acute hospital are more focused on basic life-
sustaining functions as opposed to assessing for neuropsychiatric manifestations in acute 
stroke patients, resulting in overlooked diagnoses of PSD. Dar et al. (2017) and VanItallie 
(2005) recommended that healthcare professionals be adequately trained to recognize 
depressive symptoms, use appropriate diagnostic rating scales, and be able to 
discriminate signs of depression from other disorders (e.g., dementias and normal grief 
reactions). Furthermore, like post-stroke dysphagia, PSD is also known to be undercoded 
in administrative billing data, resulting in questionable accuracy of diagnostic information 
and underreporting of diagnostic procedures (Alaghehbandan & MacDonald, 2013), 
which may misrepresent the true proportion of medical conditions and level of care 
received by patients. To address the issue of undercoding, researchers have developed 
promising case-finding algorithms with adequate sensitivity and specificity for the 
detection of PSD in administrative databases; thus, the utilization of administrative data 
for PSD research remains useful (Alaghehbandan & MacDonald, 2013; Damush et al., 
2008; West et al., 2000). Nevertheless, as with dysphagia, we should not assume that 
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depression is not present just because there is no diagnosis of PSD in the medical record. 
For this reason, the results from this study should be interpreted cautiously. 
 
Addressing Underdiagnosis and Undercoding  
Underdiagnosis and undercoding are alarming problems in healthcare because they not 
only demonstrate that patients who have serious medical conditions may not be 
identified or may be identified but their diagnosis not adequately coded, but it also 
means that these patients may not receive treatment for potentially critical conditions. 
For example, we know that post-stroke dysphagia can lead to serious complications if not 
managed, such as malnutrition, dehydration, aspiration pneumonia, and death (Labeit et 
al., 2018), and we also know that PSD is a predictor of negative outcomes after stroke, 
including disability; poor physical, social, and cognitive function; lower quality of life; and 
high mortality (Towfighi et al., 2017). Because of the prevalence and seriousness of these 
medical conditions, medical providers need to be alert to the issues of underdiagnosis 
and undercoding and be trained in not only identifying these patients but also properly 
coding for their respective medical diagnoses. As another example, increased surveillance 
for recognizing symptoms of dysphagia and depression in post-stroke patients and 
targeted and repeated (respective) dysphagia and depression screenings early in the 
acute post-stroke phase using appropriate diagnostic instruments are necessary to 
adequately detect high risk patients. Then providers can assign timely interventions 
and/or referrals as needed, potentially mitigating the risks of morbidity and mortality in 
this patient population. 
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As a result of the probable undercoding of post-stroke dysphagia and PSD in this study, 
our findings are likely grossly underestimated and more conservative than the true 
population incidences. Nonetheless, because of our large, representative sample size 
(N=9,163), our results may be more generalizable than other studies with smaller, less 
representative samples, and, to our knowledge, they establish the first reported 
incidence of PSD in Medicare patients with dysphagia who are 65 years of age and older 
after AIS. 
 
Section 4: Likelihood of PSD Diagnosis 
In the present study, fewer patients who received tPA administration were diagnosed 
with post-stroke dysphagia, which is expected given that tPA is known to reduce the 
severity of stroke. Those with a dysphagia diagnosis demonstrated significantly higher 
proportions of cognitive decline and had increased LOS (by about three days longer) than 
patients without a dysphagia diagnosis. We found that having a diagnosis of dysphagia, 
being female, being white, and having dual eligibility were positively associated with 
depression diagnosis after stroke, while age was negatively associated with PSD 
diagnosis. Compared to patients without a diagnosis of post-stroke dysphagia, those with 
a diagnosis of dysphagia were 2.7 times more likely to be diagnosed with depression after 
discharge from the acute hospital. In addition, white patients were 82% more likely to 
have a PSD diagnosis after discharge than black patients and were overall more likely to 
have a PSD diagnosis than any other race; however, due to the disproportionate number 
of white patients in this study (>80%), these results should be interpreted with caution. 
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The odds of being diagnosed with depression increased in women by 71%, and for those 
with dual eligibility, which is indicative of low socioeconomic status (SES), the odds 
increased by 43%. Age was the only factor for which the odds of PSD diagnosis were 
reduced (by 24%). 
 
Although there were very few studies by which to compare our findings, we found that 
our results were similar to Ayerbe et al.’s (2011) findings that at three months post-
stroke, dysphagic patients were almost twice as likely to have depression than non-
dysphagic patients; however, Saxena et al. (2008) found no significant association 
between PSD and dysphagia at six months after stroke (in multivariate analyses). The 
reason for the disparity may be due to variations in study methodology, sample sizes, 
diagnostic assessments and time frames, etc., which are discussed in detail below. 
Despite the discordance with Saxena et al.’s (2008) results, our findings are supported by 
other non-stroke dysphagia literature, which posit that dysphagia is associated with 
affective complaints (Verdonschot et al., 2013, 2017). In a systematic review by 
Verdonschot et al. (2017), the researchers found that all 24 articles they appraised 
suggested that depressive symptoms were significantly and positively associated with 
dysphagia. Furthermore, dysphagia is known to have severe social and psychological 
impacts that reduce quality of life, such as embarrassment, isolation, and loss of self-
esteem due to swallowing difficulties and anxiety, panic, and avoidance of meals due to 
fear of food sticking in the throat and choking (Ekberg et al., 2002). For these reasons, it 
is plausible that dysphagia is not only associated with PSD but also increases the odds of 
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PSD in post-stroke patients, as we found in the present study. Furthermore, these 
dysphagia-related psychological impacts may exacerbate or be exacerbated by similar 
psychosocial impacts of PSD, such as social withdrawal, social deterioration, and social 
discontentment (Dar et al., 2017). Given that the nature of association between post-
stroke dysphagia and PSD is not understood, it is feasible to consider that both could 
potentially contribute to, cause, or affect each other.  
 
Sienkiewicz-Jarosz et al.’s (2010) results revealed that stroke patients with more 
depressive symptoms had lower income, which was comparable to our findings with 
patients who had dual eligibility (an indicator of low SES), as were Khedr et al.’s (2020) 
results that PSD is significantly associated with lower SES. It is known that low SES is a 
determinant of poor health status, and the combination of low SES and high levels of 
psychological distress has been shown to have a multiplicative effect in which low SES 
magnifies the negative effects of psychological distress (Lazzarino et al., 2013a, 2013b). 
Furthermore, it is believed that those with lower SES possess fewer financial, social, and 
psychological resources to manage adverse events (Lazzarino et al., 2013a, 2013b; 
Matthew & Gallo, 2011); therefore, our findings that individuals with dual eligibility (an 
indicator of low SES) have increased odds of PSD compared to those who do not have 
dual eligibility are in line with the literature. 
 
With regard to gender differences, we found that women were more likely to be 
diagnosed with PSD than men, which was similar to Goldmann et al.’s (2016) findings that 
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the odds of PSD were higher in women. Conversely, our results contradicted Ayasrah et 
al.’s (2018) findings in which gender was not found to predict PSD. In the 15 studies 
examining prevalence of depression that Appelros et al. (2010) reviewed, most reported 
that PSD was more common in women than men, while others found no difference 
between women and men, and one study found a higher prevalence of PSD in men. The 
authors concluded that whether or not being a woman is a risk factor for PSD remains ill-
defined (Appelros et al., 2010). Even so, we know that there are gender-related 
differences in depression outside of the setting of stroke, with women almost twice as 
likely than men to become depressed during their lifetime (Kuehner, 2017; Salk et al., 
2017). The reasons for this “gender gap” in depression remain unclear; however, there is 
evidence to support several possible factors, including genetic susceptibility, hormonal 
influences, psychological stress responsiveness, coping styles, and social roles (Kuehner, 
2017). For example, studies have shown that women may be more likely to develop 
depression after a stressful life event (Cohen et al., 2019) and, due to gender socialization 
and cultural ideals about women, feel more comfortable seeking help when experiencing 
symptoms of depression. Additional reasons for the “gender gap” may be clinician bias 
and stereotypes about gender, in which clinicians’ diagnostic priorities tend to skew more 
toward assessing women for depressive symptoms versus men. Furthermore, clinician 
assessment methods (e.g., informal patient interview) may be biased toward depressive 
symptoms that are more characteristic in women (Sigmon et al., 2005), such as sadness 
or crying, and may not capture depressive symptoms more characteristic in men, such as 
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anger or substance abuse. For these reasons, it is plausible that after stroke, women are 
more likely to be diagnosed with depression than men, as we found in the present study. 
 
We found the odds of PSD diagnosis decreased with age, which is in agreement with 
Goldmann et al.’s (2016) findings that older patients demonstrated lower odds of PSD; 
however, our findings differed from Ayasrah et al.’s (2018) results in which age was not 
found to predict PSD. McCarthy et al. (2016) reported that at three months post-stroke, 
patients between 25-64 years of age had significantly greater depressive symptoms than 
those 65 years and older, with the 25-54 age group demonstrating the highest risk for 
depression out of all age groups examined, which is in line with our findings that older 
patients have lower odds of PSD diagnosis. The authors noted, however, that their results 
were in accordance with some similar studies but contradicted the results of others and 
suggested that these disparities were due to variability in study methods, such as using 
age as a dichotomous, instead of continuous, variable and restricting age groups in study 
samples (McCarthy et al., 2016). Furthermore, McCarthy et al. (2016) proposed that the 
association between age and PSD may be curvilinear as opposed to linear, meaning that 
risk of PSD is greatest between the ages of 25 and 54, attenuating through midlife and 
early old age, and then increasing again in late old age. Another potential reason for the 
inconsistent findings in studies examining age and PSD could be the underdiagnosis of 
depression in older individuals as a result of age-related clinician bias in which depression 
is assumed to be a normal response to a serious medical event, disease diagnosis, or 
even advancing age (Stewart, 2004). Clinicians may observe symptoms of depression but 
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not diagnose or refer an older patient for intervention if these symptoms are assumed an 
expected reaction in this particular patient age group.  
 
We found that white patients were more likely to be diagnosed with PSD than any other 
race within the three-month time period after discharge from the acute hospital; 
however, it should be noted that we had a disproportionately large number of white 
patients in our population (>80%), which can bias results. Accordingly, our findings should 
be interpreted with caution. Nevertheless, our results were similar to Goldmann et al.’s 
(2016) findings from their prospective study that comprised an adequate representation 
of Hispanic patients (50.8% Hispanic, 25.7% non-Hispanic white, and 17.5% non-Hispanic 
black) that non-Hispanic white post-stroke patients had greater odds of depression one 
month after stroke compared to other races; however, no significant differences were 
found in diagnosis of PSD between non-Hispanic white and Hispanic patients after a year. 
In Jia et al.’s (2010) retrospective study of Veterans Affairs patients utilizing 
administrative data, researchers found that post-stroke non-Hispanic white patients had 
higher odds of PSD than Hispanic and non-Hispanic black patients one year after stroke, 
which is in agreement with our findings; however, Jia et al.’s (2010) study population was 
also comprised of disproportionately greater number of white patients versus patients of 
other races/ethnicities (65.54% white, 21.9% black, 7% Hispanic, and 5.55% other), which 
could potentially bias results. In contrast to these and our findings, Sienkiewicz-Jarosz et 
al. (2010), Ayerbe et al. (2011), and Saxena et al. (2008) did not find any significant 
associations between PSD and race/ethnicity. Furthermore, they found no significant 
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associations between PSD and other demographic variables, such as age and gender, 
either. We found that our results were both consistent with and in contradiction to 
results from other studies examining variables associated with PSD, which is common in 
this area of research, especially for demographic variables (De Ryck et al., 2014; 
Kutlubaev & Hackett, 2014; Towfighi et al., 2017; Zhang et al., 2020). For example, in Shi 
et al.’s (2017a) meta-analysis, the investigators found that demographic factors, such as 
female gender and age (<70 years) were risk factors for PSD during the acute and 
subacute (≤ three months) phases, while in Babkair’s (2017) integrative systematic 
review, the investigator found that significant associations for demographic variables, 
such as gender and age, were inconsistent across studies. Several researchers who have 
conducted systematic reviews and meta-analyses have reported that because of varying 
and conflicting results in the numerous studies evaluating predictors of PSD, there are no 
consistent associations between PSD and demographic variables, such as age and gender 
(Babkair, 2017; De Ryck et al., 2014; Kutlubaev & Hackett, 2014; Towfighi et al., 2017). 
Moreover, they reported limited comparison and generalizability in most studies due to 
differences in inclusion/exclusion criteria, settings, assessment timing, and depression 
diagnostic criteria and tools; disparate variables that may be poorly quantified; 
methodological variations; and inadequate sample sizes with underpowered analyses as 
the reasons for disparities across study results (Babkair, 2017; Kutlubaev & Hackett, 
2014; Towfighi et al., 2017). As such, our ability to make direct comparisons to analogous 
studies is limited; however, we believe that we have addressed many of the authors’ 
criticisms of previous studies and, therefore, are confident that this study makes a 
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meaningful contribution to the literature by elucidating the association between the 
diagnosis of PSD and patients diagnosed with post-stroke dysphagia. 
 
Section 5: Hazard of PSD Diagnosis 
The results of our survival analyses revealed that, when controlling for significant 
covariates, the hazard for PSD diagnosis in patients with and without a diagnosis of 
dysphagia was initially low after discharge and consistently increased for the duration of 
the 90-day follow-up period; however, the group with a dysphagia diagnosis 
demonstrated an approximately 1.75-fold higher hazard for PSD diagnosis than the group 
without a dysphagia diagnosis during the 90 days after discharge, suggesting that 
patients diagnosed with dysphagia were more likely to be diagnosed with depression 
than patients not diagnosed with dysphagia. We found that on average and on any given 
day in the 90 days after discharge, the hazard for diagnosis of depression for patients 
diagnosed with dysphagia was approximately 76% greater than that for patients not 
diagnosed with dysphagia. The hazard of PSD diagnosis for women was about 67% higher 
than for men, while the hazard of diagnosis of depression for individuals with dual 
eligibility was approximately 40% higher than for those who did not have dual eligibility. 
Conversely, hazard decreased significantly by 2.5% with each year of age, suggesting that 
older stroke survivors are less likely to be diagnosed with depression. Finally, we found 
that the hazard of PSD diagnosis for white patients was 71% higher than for non-white 
patients, suggesting that white patients are at greater risk for diagnosis of depression 
than any other race; however, because of the imbalance in racial demographics in our 
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study population (white patients make up >80%), these findings should be interpreted 
cautiously. 
 
We are unable to directly compare these results to analogous studies because, to our 
knowledge, there are no studies that have examined the hazard of PSD diagnosis in 
patients diagnosed with post-stroke dysphagia; therefore, our findings may be the first to 
establish that diagnosis of dysphagia has a highly significant effect on the hazard of 
diagnosis of depression after AIS during the first 90 days after discharge from the 
hospital. Nevertheless, we can compare our findings to the few published studies that 
have assessed hazard. For example, Aben et al. (2003) included female gender and age in 
their Cox regression analyses to assess the effect of cohort (stroke versus myocardial 
infarction) on the cumulative incidence of depression, and though they did not discuss 
the hazard of these variables explicitly, their results showed that, similar to our findings, 
the hazard of depression in the stroke cohort was significantly higher (about 60%) in 
women versus men. Contrary to our findings that with every year of age, the hazard of 
PSD diagnosis significantly decreased, age was not found to be a significant covariate in 
Aben et al.’s (2003) study. Likewise, Leentjens et al.’s (2006) findings that female gender 
was not significant contradicted our results that being female significantly increased the 
hazard of being diagnosed with depression after stroke. As with studies reporting the 
odds of PSD diagnosis, our findings are consistent with some results from studies 
examining hazard, yet contrary to others. As previously discussed in detail, the reasons 
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for these disparities may be variations in methodology, sample size, inclusion/exclusion 
criteria, diagnostic timing and tools, etc. 
 
Section 6: Time to Depression Diagnosis 
With regard to time to depression diagnosis, to our knowledge, there have been no 
previous studies that have examined time from initial stroke diagnosis to depression 
diagnosis in patients diagnosed with post-stroke dysphagia; thus, the present study 
appears to be the first on this specific topic. We found the mean time to depression 
diagnosis after stroke was 40 days for patients diagnosed with dysphagia and 34 days for 
patients not diagnosed with dysphagia. Although patients with a dysphagia diagnosis 
were diagnosed with depression later than patients without a dysphagia diagnosis on 
average, these findings were not significant. Nonetheless, we also found that patients 
with a post-stroke dysphagia diagnosis had a 1.5-fold higher likelihood of being diagnosed 
with depression in the last 15 days of the 90-day post-discharge follow-up period 
compared to those without a post-stroke dysphagia diagnosis.  
 
Later Onset of PSD versus Later Diagnosis of PSD 
The reason for our findings that patients with a diagnosis of dysphagia were diagnosed 
with depression later than those without a diagnosis of dysphagia could be that 
depression actually developed during the subacute, as opposed to the acute, phase after 
stroke, which is feasible given that the literature suggests the timing of PSD is variable 
among individuals and initial onset can occur between several days to years after stroke 
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(Conroy et al., 2020). Most studies report the highest rates of PSD within the first month 
to a year after stroke, with a decline in the subsequent 12 to 24 months thereafter 
(Conroy et al., 2020; Ostir et al., 2011; Towfighi et al., 2017). Additionally, patients with a 
diagnosis of post-stroke dysphagia often have higher stroke severity (Arnold et al., 2016) 
and greater functional limitations (Castagna et al., 2019) than those not diagnosed with 
post-stroke dysphagia, requiring continuation of care at an IPR facility or SNF after 
discharge. As a result, these patients could potentially develop later-onset PSD when 
transitioning from a medical facility where they received 24-hour care, to home, where 
they experience an abrupt discontinuation of constant care and reduced socialization.  
 
Conversely, it is possible that PSD was present in patients diagnosed with dysphagia 
earlier than detected, but the diagnosis was delayed due to the previously stated reasons 
for underdiagnosis of PSD, such as barriers diagnosing patients with concurrent cognitive 
and/or language disorders and misclassification of depressive symptoms as stroke 
symptoms. Because PSD is associated with worse functional outcomes, increased 
disability, and higher mortality after stroke (Towfighi et al., 2018; Zhang et al., 2020), the 
timing of depression diagnosis is important for early identification and prompt 
intervention; however, optimal screening time after stroke is not known (Towfighi et al., 
2018). Nevertheless, it is plausible that early and recurrent depression screenings starting 




Section 7: Aim 1 Limitations 
Although retrospective, “big data” studies have many advantages, the use of large data 
sets with medical administrative data also have disadvantages and carry potential bias 
(Kaplan et al., 2014), which are the main reasons for the limitations of this study. First, 
because administrative data consists of medical and billing code sets and were not 
collected specifically for research purposes, crucial information and details about 
patients may be omitted, such as premorbid level of function (e.g., disability, 
dependence); diagnostic methods and severity (of dysphagia and depression); and 
behavioral, environmental, and social factors (Kaplan et al., 2014). For example, although 
we removed patients with a diagnosis of dysphagia or depression within 90 days prior to 
stroke from the data set, we cannot be sure that those patients did not have a prior 
history of or undiagnosed dysphagia or depression before our 90-day pre-stroke cutoff. 
Second, sampling bias limits the generalizability of the study results to the population 
actually represented in the data set (Kaplan et al., 2014), which in our case, limits 
generalizability to those 65 year of age and older who receive Medicare benefits and 
excludes stroke survivors younger than 65 and those who do not have Medicare. Third, 
coding errors and misclassification bias are recognized limitations in the use 
administrative data (Cohen et al., 2020), and since undercoding of dysphagia and 
depression is well-known (Cohen et al., 2020; Gonzalez-Fernandez et al., 2009), our 
findings may be conservative and the true population values are likely underestimated. 
 
 
Aim 2 Discussion 
Section 1: Brief Summary of Results 
Objectives 
Because claims data lack clinical details about disease severity, a proxy for severity is 
needed to adequately utilize and analyze administrative data (Gonzalez-Fernandez et al., 
2009). To our knowledge, there is currently no method for post-stroke dysphagia severity 
classification for use with administrative data. Thus, we saw an opportunity to address 
this gap in the literature. Accordingly, our first objective for Aim 2 was to create a novel 
proxy index for dysphagia severity for use with administrative data (called the ADDSS). 
The second objective was to use this novel proxy index to stratify our sample based on 
inferred dysphagia severity and determine if post-stroke dysphagic patients with varying 
degrees of dysphagia severity had different PSD-related outcomes. Therefore, we 
examined if dysphagia severity, via the ADDSS, was related to differences in PSD diagnosis 
as well as time to PSD diagnosis within a 90-day post-discharge follow-up period in post-
stroke dysphagic patients. 
 
Hypotheses and Results 
For hypothesis 1, we used a stable subset of ICD-10 dysphagia diagnosis and procedure 
codes to develop a clinically relevant, novel dysphagia severity index for use with 
administrative data – the ADDSS. Cluster validation subsequent to the development of 
the ADDSS revealed an interesting and unanticipated finding that dysphagia severity 




details in Section 3.) Then we applied the ADDSS to our data set to test hypothesis 2 and 
its sub-hypotheses, which we found were not supported by our data. We did not find 
that patients in different dysphagia severity groups had significantly different risk of PSD 
diagnosis after discharge (hypothesis 2), nor did we find a statistically significant 
difference in proportions of PSD diagnosis across dysphagia severity groups within the 90 
days after discharge (hypothesis 2a). Furthermore, no significant effect was found 
between dysphagia severity and the odds of receiving a PSD diagnosis in the 90 days after 
discharge (hypothesis 2b). Lastly, the data did not support that post-stroke patients with 
a diagnosis of PSD and more severe dysphagia had a shorter time to first depression 
diagnosis compared to those with a diagnosis of PSD and less dysphagia severity 
(hypothesis 2c). These results are discussed in detail in Sections 4 and 5.  
 
Section 2: Construct Validity of the ADDSS 
Utility of the ADDSS 
Large administrative databases are being used more often in dysphagia research, 
especially in studies of stroke (Bartlett & Thibeault, 2018). In a recent review by Bartlett 
and Thibeault (2018), the authors examined research articles that used administrative 
datasets or clinical registries to study dysphagia, and almost half of the articles focused 
on stroke. Thus, there is great value and importance in developing instruments 





Because the ADDSS algorithm was shown to be valid and produced stable dysphagia 
severity clusters, it can be used in post-stroke dysphagia research when stratification by 
dysphagia severity is desired. It could also potentially be helpful in other aspects of post-
stroke dysphagia research, such as epidemiologic post-stroke dysphagia incidence and 
prevalence reporting, identifying dysphagic subgroups (e.g., patients with dysphagia-
related sequelae), and capturing the burden of post-stroke dysphagia (e.g., healthcare 
utilization and cost). Additionally, we developed the ADDSS and performed a subsequent 
subgroup sensitivity analysis with an inpatient population and then applied the ADDSS to 
an outpatient population – all of which revealed similar results. Therefore, we believe 
that the ADDSS may have utility in grouping post-stroke patients into disparate dysphagia 
severity groups in both inpatient and outpatient stroke populations as well; however, this 
should be further explored in future studies.   
 
Other Administrative-Level Instruments 
There are no other administrative-level post-stroke dysphagia severity classification 
instruments available to compare to the ADDSS; however, there other stroke severity 
instruments designed to be used with U.S. administrative data for which we may conduct 
indirect comparisons. For example, the Stroke Administrative Severity Index (SASI; 
Simpson et al., 2017) is a valid measure of stroke severity at hospital discharge for use 
with administrative claims data. Like the ADDSS, the SASI was developed using similar 
source data (the Medicare 5% LDS) and methods. That is, exploratory cluster analysis was 
used to group together patients who had similar International Classification of Diseases 
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[ICD] diagnosis and procedure codes (ICD-9 for the SASI and ICD-10 for the ADDSS) into 
distinct clusters – three stroke severity clusters for the SASI (mild, moderate, and severe) 
and three dysphagia severity clusters for the ADDSS (mild, moderate, and severe). 
Additionally, both the SASI and the ADDSS were based on the NIH Stroke Scale (NIHSS), 
which was used as the theoretical framework and for internal and external validation for 
the SASI and for construct validation of the dysphagia severity groups for the ADDSS.  
 
Additional examples of stroke severity instruments for use with administrative data in 
stroke research are the Administrative Data Stroke Scale (ADSS) and the Administrative 
Stroke Outcome Variable (ASOV; Patel et al., 2021). The ADSS and ASOV were designed 
for use in population-wide studies – the ADSS measuring stroke severity at admission and 
the ASOV as an estimate for 90-day modified Rankin Scale (mRS). The ADSS was 
developed using the National Inpatient Sample (NIH), an all-payer U.S. national and 
regional inpatient database. Similar to our instrument (ADDSS) design, Patel et al. (2021) 
also used the NIHSS as a template for their ADSS and selected variables based on ICD-9 
diagnostic and procedural codes as indicators of stroke severity. Instead of cluster 
analysis, the researchers used forward selection stepwise multivariable logistic regression 
to develop the ADSS. Then they used the ADSS model to predict poor functional 
outcome, which was defined using the ASOV as “good outcome” versus “bad outcome” 
to differentiate patients with minimal-to-moderate post-stroke disability from those with 
severe disability (Patel et al., 2021). To validate their instruments, the researchers used 
two separate cohorts for external validation.   
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These stroke severity instruments have similarities to our ADDSS in their implementation 
with administrative data, some comparable development methods, and their (potential) 
utility. The SASI, ADSS, and ASOV were designed to categorize stroke severity and can 
also be used to predict and answer questions about comorbidities. They have great utility 
in addressing the challenges of studying administrative claims data for stroke patients 
from which valuable information may be absent, such as admission and discharge NIHSS 
scores and 90-day mRS outcomes. They adjust for stroke severity differences in 
population-wide stroke studies to not only allow for comparisons with studies that do not 
use administrative data (e.g., clinical trials) but also to limit confounding of stroke 
severity in administrative-level studies. The ADDSS is a dysphagia-specific instrument for 
use with AIS patients with the purpose of categorizing patients into disparate dysphagia 
severity clusters. It also has potential for being used as a prediction tool and for 
answering questions about comorbidities. In future research, we not only plan to conduct 
reliability and validation studies with the ADDSS, but we also plan to further explore the 
utility of the ADDSS for predicting depression diagnosis in post-stroke dysphagic patients, 
such as how the ADDSS severity groups could be used to predict swallow function 
recovery in the acute hospital setting. For example, perhaps individuals with mild post-
stroke dysphagia (per the ADDSS classification) may spontaneously recover swallow 
function without intervention, while those with moderate dysphagia may recover 
swallow function with minimal therapy, and individuals with severe dysphagia will 
recover swallow function with maximum therapeutic intervention (or recover only some 
swallow function or none at all). Although future studies are promising, currently, the 
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ADDSS is not yet a validated instrument. Thus, an important question is: Since there are 
already validated administrative-level stroke severity instruments available, could we use 
those to estimate dysphagia severity, instead of developing a dysphagia-specific index? 
 
Section 3: Why is a Dysphagia-Specific Index Needed? 
Association Between Stroke Severity and Dysphagia Severity 
There is evidence in the literature that stroke severity is not only associated with 
dysphagia, but it is also predictive of dysphagia severity (De Stefano et al., 2021; 
Jeyaseelan et al., 2015; Khedr et al., 2021; Otto et al., 2016; Takizawa et al., 2016). 
Jeyaseelan et al. (2015) conducted a retrospective study of stroke patients in an inpatient 
acute rehabilitation unit to determine the utility of the NIHSS as a predictor for post-
stroke dysphagia (via modified barium swallow study [MBSS] and/or radiographic 
evidence of aspiration pneumonia). The researchers found that the presence of 
dysphagia was significantly correlated with stroke severity, with the proportion of 
dysphagic patients generally increasing as NIHSS score increased (Jeyaseelan et al., 2015). 
An NIHSS score with a cut-off of >9 demonstrated sensitivity of 75%, specificity of 62%, 
positive predictive value (PPV) of 46%, and negative predictive value (NPV) of 85% and, 
therefore, was determined to be moderately predictive of dysphagia (Jeyaseelan et al., 
2015). In a retrospective study at a tertiary hospital, De Stefano et al. (2021) examined 
factors that contributed to the severity and persistence of dysphagia in subacute stroke 
patients. The researchers found that an admission NIHSS score of >12 was significantly 
predictive of moderate or severe dysphagia (measured by the American Speech-
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Language-Hearing Association (ASHA) National Outcome Measurement System (NOMS) 
score) after 60 days (De Stefano et al., 2021). Otto et al.’s (2016) cross-sectional, 
prospective study of acute stroke patients demonstrated a statistically significant 
correlation between stroke severity (NIHSS score) and dysphagia severity (via the 
Protocol for Investigation of Oropharyngeal Dysphagia in Adults), with an NIHSS score of 
0-6 (minor stroke, per the researchers’ definition) correlated with normal swallowing and 
mild dysphagia and an NIHSS score of ³16 (severe stroke, per the researchers’ definition) 
correlated with severe dysphagia. Although there is some evidence to support the NIHSS 
being potentially predictive of post-stroke dysphagia severity, adequate sensitivity, 
validity, and reliability have not yet been demonstrated for its use as a prediction tool for 
dysphagia severity. For these reasons, there is not sufficient evidence to support the use 
of a stroke severity instrument to estimate dysphagia severity in research with 
administrative data at this time. 
 
Discordance Between Stroke Severity and Dysphagia Severity 
In discordance with the aforementioned literature, our study results showed that 
dysphagia severity (ADDSS) did not coincide with stroke severity (NIHSS score). That is, 
our dysphagia severity cluster classification did not extend to stroke severity 
classification. For example, we found that patients in the mild ADDSS group primarily had 
cases of cognitive impairment but showed little evidence of feeding or nutrition problems 
(important indicators of dysphagia) and demonstrated almost no indication of respiratory 
compromise. Accordingly, we presumed that patients in the mild ADDSS group would 
 113 
 
also present with mild stroke; however, that was not supported by the data. Conversely, 
the mild ADDSS group contained 63% of the total attributes (dysphagia indicator 
variables constructed from dysphagia-related ICD-10 diagnosis and procedure codes in 
the cluster analysis), which are suggestive of stroke-related illness. Additionally, patients 
in this group had NIHSS scores indicative of moderate stroke (mean, 10.08; SD, 7.93). 
Thus, we determined that patients in the mild ADDSS group actually had moderate 
stroke. 
 
Patients in the moderate ADDSS group had the most cases of respiratory compromise 
compared to the other clusters, including such attributes as respiratory problems, 
aspiration pneumonia, intubation, and tracheotomy/tracheostomy; however, dysphagia 
severity was judged not by aspiration pneumonia, which is known to be difficult to 
differentiate from other pneumonia types and is often misdiagnosed (Son et al., 2017), 
but by feeding device placement, which is a (reliable) key marker for dysphagia severity. 
Because the feeding device placement mean (the metric by which we graded the clusters 
into qualitative categories) was the second highest out of all three clusters, we 
determined that patients in this group had moderate dysphagia severity. Again, we 
presumed that patients in the moderate ADDSS group would also present with moderate 
stroke; however, that was not supported by the data. This group contained 100% of the 
total attributes, suggesting that patients were very ill, and patients had NIHSS scores 
indicative of moderate/severe stroke (mean, 16.23; SD, 8.18). Thus, we determined that 
patients in the moderate ADDSS group actually had moderate/severe stroke. It seemed 
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that stroke severity indicators captured respiratory issues associated with respiratory 
compromise and aspiration pneumonia in these patients but not dysphagia. This is 
further supported by intubation in this cluster being likely driven by diagnoses of 
respiratory conditions, not dysphagia severity, given the overwhelming presence (and 
higher means) of respiratory compromise attributes versus feeding/nutrition attributes. 
 
Patients in the severe ADDSS group demonstrated dysphagia severity in the setting of 
alternative nutrition with the highest means for feeding device placement (primary 
marker for dysphagia), malnutrition, and dehydration compared to the other clusters. 
Accordingly, we presumed that patients in the severe ADDSS group would also present 
with severe stroke; however, that was not supported by the data. This group also showed 
evidence of aspiration pneumonia and cognitive impairment and contained 75% of the 
total attributes, suggesting that patients in this group had substantial stroke-related 
illness; however, patients in the severe ADDSS group had NIHSS scores indicative of 
moderate stroke (mean, 13.51; SD, 7.78). Thus, we determined that patients in the 
severe ADDSS group actually had moderate, not severe, stroke. 
 
Because of the incongruity between NIHSS scores and ADDSS clusters found in this study, 
it is important to recognize that stroke severity and dysphagia severity are not 
synonymous. For this reason, when conducting (administrative-level) dysphagia severity 
research, general stroke severity instrument instruments should not be used when the 
outcome of interest is dysphagia-specific. 
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General Versus Disease-Specific Instruments 
There are advantages and disadvantages to both general (generic) and disease-
/condition-specific instruments that measure health-related outcomes. For example, in 
QOL scales used to measure health related QOL (HRQOL), which may include outcome 
measures like patient perception, presence/absence of symptoms, and/or functional 
limitations (e.g., physical, psychosocial, etc.; Timmerman et al., 2014), general 
instruments are advantageous because of their broader content and applicability across 
diverse clinical populations. This allows for comparisons across diseases/conditions; 
however, because general instruments were designed to allow for generalizability, they 
lack specificity. Conversely, disease-specific instruments, which are designed for use with 
specific patient populations, have the benefit of measuring more specific symptoms, 
resulting in increased responsiveness and clinical utility compared to general QOL 
instruments (Hobart et al., 2002; Ware et al., 2016). The main disadvantage of disease-
specific instruments is that they cannot be used or compared across diseases/conditions. 
 
An example of a general (generic) instrument is the Centers of Disease Control and 
Prevention HRQOL 14-Item Measure (CDC HRQOL–14 Measure), which is a population 
measure for HRQOL that consists of broad questions, such as perceived health status, 
activity limitations, pain, depression, anxiety, sleeplessness, etc. (Hennessy et al., 1994; 
Moriarty et al., 2003), and can be used with a variety of populations. Although it has 
many beneficial applications for general use, its utility is not adequate when assessing 
diagnostic specific HRQOL. An example of a disease-/condition-specific instrument is the 
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Stroke Specific Quality of Life scale (SS-QOL), which is a well-known assessment of HRQOL 
for patients with stroke (Williams et al., 1999). The SS-QOL can be used across patients 
with various types of stroke; however, it was not designed for use to measure outcomes 
about specific stroke-related diagnoses. It measures post-stroke HRQOL using 12 
domains, including energy, upper extremity function, work/productivity, mood, self-care, 
social roles, family roles, vision, language, thinking, and personality. Although this 
instrument was specifically designed for use with stroke survivors, there is no domain for 
dysphagia, which is a common sequela of stroke. The only items that are remotely 
related to dysphagia are under the Self-Care domain; however, those items involve 
assistance preparing or cutting food, not the act of eating, drink, or swallowing. Thus, 
even though SS-QOL is a disease-/condition-specific instrument designed for use in stroke 
patients, its use would not be appropriate for post-stroke dysphagic patients if the 
outcomes of interest are dysphagia-specific. Another QOL instrument that was developed 
based on the SS-QOL is the Stroke and Aphasia Quality of Life Scale (SAQOL-39), which 
was designed for stroke survivors with long-term aphasia (Hilari et al., 2003). The disease-
/condition-specific SAQOL-39 has four domains, including physical, psychosocial, 
communication, and energy, with items adapted from the original SS-QOL specifically for 
individuals with aphasia. To improve content validity, the SAQOL-39 also has four 
additional items (not part of the SS-QOL) related to speech, language, and cognitive 
difficulties. Similar to the SAQOL-39, there is a dysphagia-specific QOL scale called the 
Swallowing Quality of Life (SWAL-QOL), which is a measure of QOL in individuals with 
swallowing disorders (McHorney et al., 2000a, 2000b, 2002). The SWAL-QOL has 10 
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domains, including burden, eating duration, eating desire, food selection, 
communication, fear, mental health, social, sleep, and fatigue, that are specific to 
swallowing/dysphagia.  
 
We know that it is vital to use appropriate clinical assessments in patient populations for 
which they were designed to maintain the validity and interpretability of the instrument. 
For instance, in clinical research, investigators would not use a general QOL assessment 
to examine QOL in dysphagic patients, given that there is a swallowing-specific scale 
available, such as the SWAL-QOL. Likewise, in research involving administrative data, 
disease-specific instruments should be utilized (when available) over general instruments 
to ensure the most rigorous results. 
 
Need for Dysphagia-Specific Instruments for Administrative Data 
Administrative claims data reflect clinical practice; however, crucial information required 
to discern dysphagia severity in post-stroke patients, such as dysphagia diagnostic 
instrument results, oral health status, and diet texture and liquid consistency levels, is not 
captured. For this reason, it is compulsory that an appropriate administrative-level, 
dysphagia-specific instrument be developed for use with post-stroke patients. To this 
end, we have proposed the ADDSS in lieu of the few other general stroke severity 




The ADDSS also has potential for utility in research that combines administrative data 
with clinical data. For example, the ADDSS severity levels could be used adjunctively with 
data collected clinically from the Functional Oral Intake Scale (FOIS), which measures 
change in functional eating abilities over time in post-stroke patients (Crary et al., 2005). 
The categorization of the seven levels of the FOIS lend themselves to the ADDSS severity 
levels, such that FOIS levels 1-2 (nothing by mouth to feeding tube dependent with 
minimal attempts with food/liquid) correspond to ADDSS severe dysphagia severity, FOIS 
levels 3-4 (feeding tube dependent with consistent oral intake to total oral diet of single 
consistency) correspond to ADDSS moderate dysphagia severity, and FOIS levels 5-7 
(total oral diet with multiple consistencies, requiring special preparation or 
compensations to total oral diet with no restrictions) correspond to ADDSS mild 
dysphagia severity. The ADDSS severity levels may also be suitable in conjunction with 
clinical data from the International Dysphagia Diet Standardisation Initiative (IDDSI) levels 
(Cichero et al., 2017), such that IDDSI 7 (regular/easy to chew), 6 (soft and bite size), 0 
(thin), and 1 (slightly thick) correspond to ADDSS mild severity; IDDSI 5 (minced & moist) 
and IDDSI 2 (mildly thick) correspond to ADDSS moderate severity; and IDDSI 3 
(liquidised/moderately thick) and IDDSI 4 (pureed) correspond to ADDSS severe severity. 
The ADDSS could also potentially have applicability for use with clinical data from the 
Eating Assessment Tool (EAT-10), which estimates initial dysphagia severity and monitors 
treatment response (Belafsky et al. 2008). The next steps in this line of research are to 
conduct validity and reliability testing of the ADDSS for its use in administrative data 
research to classify post-stroke dysphagia severity. 
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Section 4: Diagnosis of PSD by Dysphagia Severity 
To our knowledge, there have been no previous studies that have examined the 
association between dysphagia severity and depression diagnosis in patients diagnosed 
with post-stroke dysphagia; thus, the present study appears to be the first on this specific 
topic. We hypothesized that patients in different dysphagia severity groups would have 
different risk of PSD diagnosis after discharge (hypothesis 2); however, our results were 
not supportive of this hypothesis. We found no statistically significant difference in risk of 
PSD diagnosis after discharge by dysphagia severity. Thus, our hypothesis that post-
stroke patients with more severe dysphagia would have greater odds of PSD diagnosis 
within the 90 days after discharge (2b) was also not supported. Additionally, we 
hypothesized that post-stroke patients with more severe dysphagia would have a greater 
proportion of PSD diagnosis within the 90 days after discharge (2a); however, we found 
that the proportions of patients diagnosed with PSD across all three dysphagia severity 
groups were very similar (17%, 14%, and 16%, p=0.9016, respectively), revealing no 
statistically significant difference. Thus, the evidence was not supportive of this 
hypothesis either.  
 
Although we were unable to directly compare our results to analogous studies because, 
to our knowledge, there are no other administrative-level studies of post-stroke 
dysphagia and PSD in the literature, we were able to make general comparisons to the 
few non-stroke clinical studies that have examined dysphagia severity and depression. 
For example, Nguyen et al. (2005) conducted a retrospective study of patients treated for 
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head-and-neck cancer (HNC) with dysphagia at a Veterans Affairs (VA) hospital and found 
that dysphagia severity (measured by MBSS) was significantly and positively correlated 
with depression (measured by the Hospital Anxiety-Depression Scale-Depression [HADS-
D]), with patients with moderate to severe dysphagia demonstrating greater depression 
scores than those with mild dysphagia. Our results that post-stroke dysphagia severity 
was not significantly associated with depression diagnosis were dissimilar to Nguyen et 
al.’s (2005) findings. The discordance in findings is primarily a result of the limitations in 
comparing prospective versus retrospective studies (e.g., study methodology, sample 
sizes, diagnostic assessments used, timing of assessments, etc.) and comparing disparate 
patient populations (stroke versus HNC). In a prospective study of patients with HNC and 
dysphagia at an outpatient clinic, Krebbers et al. (2020) found that the presence of 
aspiration during fiberoptic endoscopic evaluation of swallowing (FEES), signifying 
increased dysphagia severity, was significantly associated with lower depression scores 
(measured by the HADS-D). That is, patients who presented with more severe dysphagia 
reported fewer symptoms of depression than those who presented with less severe 
dysphagia. Our findings were contradictory to Krebbers et al.’s (2020) results in that we 
found no significant association between dysphagia severity and depression. The reasons 
for discordance between Krebbers et al.’s (2020) and our findings are likely the same as 
with Nguyen et al.’s (2005) study findings. Additionally, the discrepancy in our respective 
results could also be heavily influenced by our disparate patient populations and time 
intervals. Krebbers and colleagues (2020) examined patients at least six months after 
their HNC treatments who were in total remission. It is feasible that, in time, patients 
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who are medically stable and disease-free may adjust to their dysphagia symptoms or 
limitations (Krebbers et al., 2020), such as the patients who had HNC, and 
experience/report fewer symptoms of depression. In another prospective study, 
Verdonschot et al. (2016) studied patients with dysphagia at an otorhinolaryngology 
outpatient clinic to determine the relationship between dysphagia severity and affective 
symptoms. The patient sample included individuals with HNC at least six months post-
treatment, patients with a neurologic diagnosis (e.g., Parkinson’s disease, stroke) 
considered stable and/or who had received stable medication management for at least 
three months, and patients with other medical diagnoses (e.g., Zenker’s diverticulum, 
cervical spine degeneration; Verdonschot et al., 2016). The researchers did not find any 
significant associations between dysphagia severity via FEES and clinically relevant 
symptoms of depression (measured by HADS-D; Verdonschot et al., 2016), which was 
consistent with our findings. Nevertheless, there were limitations to Verdonschot et al.’s 
(2016) study that could have affected their results. For example, the researchers used 
FEES to measure dysphagia severity; however, they proposed that if another diagnostic 
instrument had been used, such as MBSS, manometry, or electromyography, dysphagia 
severity results may have been different (Verdonschot et al., 2016). Furthermore, some 
literature suggests that the use of the HADS-D to measure depressive symptoms has 
disadvantages, such as low sensitivity and specificity for detecting depressive symptoms 
in certain populations of older adults (Edelstein et al., 2010). Other study limitations 
reported by Verdonschot et al. (2016) included methodologic issues, such as 
heterogeneity of the study sample and a small sample size, resulting in small subgroup 
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sizes, which limited the types of subgroup analyses that could be conducted. Finally, 
because of the underlying association between HNC and neurologic diseases with 
affective symptoms, researchers could not definitively attribute depressive symptoms to 
dysphagia alone (Verdonschot et al., 2016). For these reasons, the results of Verdonschot 
et al.’s (2016) study should be interpreted with caution. 
 
There is evidence in the literature, and from Aim 1 of this study, to support that 
dysphagia is associated with depression (Dziewas, et al., 2017; Holland, 2011; 
Verdonschot et al., 2013, 2017); however, there is a paucity of studies examining the 
relationship between dysphagia severity and depression. For this reason, we cannot yet 
draw definitive conclusions from the results of this study. We can, however, consider the 
reasons why we may have found no association between post-stroke dysphagia severity 
and diagnosis of PSD in the 90 days after discharge from the hospital. The first possibility 
is that there may not be a relationship between dysphagia severity and depression, which 
is consistent with Verdonschot et al.’s (2016) findings, and that the association between 
dysphagia and depression is irrespective of dysphagia severity. That is, having dysphagia 
is what matters most in relation to depression, despite severity. The second potential 
explanation of our findings is timing. Our study time period was limited to the 90 days 
after discharge, and we know from the literature that timing of PSD is variable among 
individuals, with initial onset occurring between several days to years after stroke 
(Conroy et al., 2020). Therefore, it is feasible that patients without a depression diagnosis 
presented with depression at a later time that occurred outside of this study, which we 
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were not able to capture. The third possible reason for our results is that there is, in fact, 
an effect of dysphagia severity on PSD diagnosis, which would be consistent with Nguyen 
et al.’s (2005) and Krebbers et al.’s (2020) findings; however, underdiagnosis and 
undercoding of dysphagia and PSD, which are well-documented phenomena, could have 
been barriers in detecting the true proportions of patients with diagnoses of post-stroke 
dysphagia and PSD (Cohen et al., 2020; Dar et al., 2017; Gonzalez-Fernandez et al., 2008). 
 
Section 5: Diagnosis of PSD by Dysphagia Severity and Time 
With regard to time to depression diagnosis, to our knowledge, there have been no 
previous studies that have examined time from initial stroke diagnosis to depression 
diagnosis stratified by dysphagia severity in patients diagnosed with post-stroke 
dysphagia; thus, the present study appears to be the first on this topic. We hypothesized 
that post-stroke patients with more severe dysphagia and a diagnosis of PSD would have 
a shorter time to first depression diagnosis (2c); however, found the (statistically 
significant) mean time to depression diagnosis after stroke was 39 days for patients with 
mild dysphagia, 63 days for patients with moderate dysphagia, and 70 days for patients 
with severe dysphagia. Patients with mild dysphagia were diagnosed with PSD sooner on 
average than the patients with more severe dysphagia; thus, the evidence was not 
supportive of our hypothesis (2c). Additionally, we found that 50% of patients with mild 
dysphagia had a diagnosis of depression a little more than one month after discharge, 
while 50% of patients with moderate or severe dysphagia had a diagnosis of depression 
almost at the end of the 90-day post-discharge follow-up period. 
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A reason for our findings that patients with mild dysphagia were diagnosed with PSD 
sooner than those with more severe dysphagia after discharge could be due to 
healthcare providers’ focus on medical, not psychological, conditions in patients with 
greater dysphagia severity, given the risks of serious complications, such as malnutrition, 
dehydration, aspiration pneumonia, compromised overall health, and mortality (ASHA, 
n.d.). Thus, providers could potentially overlook the symptoms of depression in these 
more severely dysphagic patients, while depressive symptoms in patients with less 
dysphagia severity, who may be considered at lower risk for complications, more easily 
attract the attention of healthcare providers. Another explanation of our findings could 
be a result of clinician training and experience compounded by discharge disposition. 
Depressive symptoms can be challenging to recognize by untrained and/or inexperienced 
healthcare providers because they typically present as somatic (e.g., fatigue) and/or 
other affective symptoms (e.g., guilt, worthlessness, lack of interest) in older adults, not 
depressed mood, which may be mistakenly attributed to stroke or cognitive impairment, 
instead of PSD (Dar et al., 2017; Lökk & Delbari, 2010; VanItallie, 2005). Furthermore, 
discharge disposition may also play a role in our results in that patients with mild 
dysphagia may be discharged to a location (e.g., IPR facility, home with home health) 
where they may receive attention from healthcare providers who have adequate training 
to recognize the symptoms of PSD, such as physical medicine and rehabilitation (PM&R) 
physicians or neuropsychologists at an IPR facility or a patient’s primary care physician 
who knows their baseline function if discharged home. Conversely, patients with more 
severe dysphagia, potentially requiring alternative nutrition via feeding tube, may be 
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discharged to a SNF where there may not be healthcare providers trained in recognizing 
symptoms of PSD, which may explain why these patients were not diagnosed with 
depression on average until the end of the 90-day post-discharge follow-up period. 
 
Another reason for our findings could be the time interval of this study, which was within 
the 90 days after discharge from the acute hospital. Since “early” onset of PSD is defined 
as symptoms of PSD within the first three months after stroke, and “late” onset is 
considered any time subsequently (Lökk & Delbari, 2010), it is possible that patients in 
this study who were not diagnosed with depression experienced late onset PSD outside 
of the study time frame, in which case, their diagnoses were not captured.  
 
The final reason for our study results could be the well-known problem of undercoding 
and underdiagnosis of dysphagia and depression in administrative data (Cohen et al., 
2020; Conroy et al., 2020; Dziewas, et al., 2017; Gonzalez-Fernandez et al., 2008; Labeit 
et al., 2018; Rofes et al., 2011; Takizawa et al., 2016; Starkstein & Robinson, 1989), which 
may underestimate the true population values. Undercoding and underdiagnosis of 
dysphagia are due to a number of factors, including lack of available dysphagia specialists 
(speech-language pathologists [SLPs]), limited access to diagnostic equipment or 
resources in certain medical settings, lack of consensus for which patients require 
dysphagia screening, and use of inappropriate diagnostic tools with varying sensitivities 
for detecting dysphagia (Dziewas, et al., 2017; Labeit et al., 2018; Rofes et al., 2011; 
Takizawa et al., 2016). Similarly, undercoding and underdiagnosis of depression are due 
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to factors, such as lack of healthcare provider training/experience, misclassification of 
symptoms of depression in the setting of post-stroke cognitive and/or language 
impairments and use of screening tools with inadequate sensitivity for detecting 
depression (Conroy et al., 2020; Starkstein & Robinson, 1989; Williams, 2005).  
 
Section 6: Aim 2 Limitations 
We had the same limitations for Aim 2 as we had for Aim 1, with another example of key 
information missing from administrative data being the lack specific medical codes for 
important dysphagia-related considerations, such as diet texture, liquid consistency, 
edentulous status, etc., which would be advantageous in a more robust classification of 
dysphagia severity clusters. Additionally, using a subset of patients who had documented 
NIHSS scores for Aim 2 had disadvantages in that (1) it substantially reduced our sample 
size for Aim 2, and (2) it introduced bias, as not all facilities record the NIHSS in practice, 
particularly not the smaller community or rural hospitals; therefore, patient data 
containing NIHSS scores may disproportionately represent patients from large, 
comprehensive stroke centers. Furthermore, cluster analysis is typically conducted on 
large sample sizes, but our NIHSS sample size was much smaller than our original sample 
size, potentially yielding less robust results. A future ADDSS validation study should be 




 Section 1: Brief Summary of Results 
Objectives 
Our objective was to compare the mean healthcare costs in post-stroke dysphagic 
patients with and without a depression diagnosis in the 90-day follow-up period after 
discharge from the acute hospital. Additionally, we applied the ADDSS to our data set to 
analyze post-discharge costs in patients diagnosed with depression, stratified by 
dysphagia severity. 
 
Hypotheses and Results 
We studied 359 Medicare beneficiaries hospitalized for AIS with a secondary diagnosis of 
post-stroke dysphagia and examined their healthcare costs over a 90-day post-discharge 
period in 2017. Fifteen percent of post-stroke dysphagic patients had a diagnosis of 
depression. Consistent with our Aim 3 hypothesis, we found that dysphagic patients with 
a PSD diagnosis had greater total healthcare costs in the 90 days after discharge than 
dysphagic patients without a PSD diagnosis. Stratifying for dysphagia severity using the 
ADDSS revealed the same results, that patients with depression and dysphagia 
(irrespective of dysphagia severity) incurred higher total healthcare costs in the 90 days 
after discharge compared to dysphagic patients without depression, with an unadjusted 
additional cost of $12,667. Furthermore, we found that stroke severity and dysphagia 
severity significantly contributed to the variations in cost, as seen in an increase in 




dysphagia severity and stroke severity). Additionally, we found that the presence of 
depression resulted in a 36% increase in cost after controlling for dysphagia severity and 
stroke severity. These results are discussed in detail below. 
 
Section 2: Cost Analysis 
Unadjusted Cost 
When examining unadjusted total cost by dysphagia severity groups and depression 
diagnosis, we found that patients with mild and severe dysphagia with a depression 
diagnosis incurred higher mean total costs ($15,914 and $11,680, respectively) than 
those without a depression diagnosis in the same dysphagia severity groups, while those 
with moderate dysphagia and a depression diagnosis incurred $316 lower mean total 
costs compared to patients with moderate dysphagia without a depression diagnosis. We 
also found that patients with moderate dysphagia had higher unadjusted mean inpatient 
costs after discharge than those with mild or severe dysphagia, meaning that patients 
with moderate dysphagia had more post-discharge readmissions to the acute hospital 
and/or inpatient rehabilitation admissions.  
 
Although counterintuitive at first glance, these findings are compatible with the medical 
characteristics of patients in the moderate dysphagia severity group. These patients had 
moderate/severe stroke severity (the highest stroke severity of the three dysphagia 
groups) and were very ill as evidenced by the many comorbidities/complications in this 
group, including cognitive impairment, malnutrition, dehydration, and feeding tube use. 
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In addition, patients in the moderate dysphagia group demonstrated the highest 
proportions of respiratory comorbidities, including intubation and 
tracheotomy/tracheostomy. Thus, the higher post-discharge inpatient costs for acute 
hospital readmissions were likely driven by their stroke severity (with greater stroke 
severity a predictor for worse outcomes; Adams et al., 1999) and serious respiratory 
issues. Furthermore, because this group had moderate/severe stroke severity, likely 
resulting in greater impairment and disability, they presumably required more intensive 
rehabilitation. Accordingly, this group had the largest proportion of discharge to IPR 
facilities compared to the mild and severe dysphagia groups, which also contributed to 
their higher post-discharge inpatient costs. Conversely, we did not find a notable 
difference in mean total costs between patients with and without depression in the 
moderate dysphagia group. The reason for this is likely due to cost of care being primarily 
dictated by moderate/severe stroke severity and respiratory complications, which may 
have obscured any depression-related costs.  
 
Adjusted Cost 
When measuring the effect of PSD and dysphagia severity in combination on total 90-day 
post-discharge cost, we found that having mild dysphagia with a PSD diagnosis was 
significantly associated with higher total 90-day costs and that stroke severity had a 
significant effect on cost. Controlling for stroke severity, the marginal cost difference was 
$15,914 higher for patients with mild dysphagia and a diagnosis of depression compared 
to those with mild dysphagia without a diagnosis of depression, which supported our 
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hypothesis that patients with post-stroke dysphagia and PSD with incur greater 
healthcare costs than post-stroke dysphagic patients without PSD. These findings are also 
in line with our findings from Aim 2 in which patients with mild dysphagia were 
diagnosed with PSD sooner than those with moderate or severe dysphagia. Thus, it is 
logical that patients with mild dysphagia, who were diagnosed with PSD early in the 90-
day post-discharge follow-up window and likely received treatment for depression earlier 
in the post-discharge follow-up period, would incur higher post-discharge costs than 
those with mild dysphagia without the addition disease burden and those with more 
severe dysphagia severity, who were not diagnosed with PSD until much later in the 90-
day post-discharge window. It is important to note that the dysphagia severity groups 
had an unequal number of observations for each cluster (mild: n=266, moderate: n=42, 
and severe: n=51), which could explain why associations between depression diagnosis 
and moderate and severe dysphagia severity, respectively, did not reach statistical 
significance, despite having similar directionality as the significant result.  
 
To moderate the effect of the small number of observations in the moderate and severe 
dysphagia severity clusters and better understand the cost differences between the mild 
dysphagia and moderate and severe dysphagia groups, we “collapsed” the moderate and 
severe categories into one group, creating a dichotomized variable, “mild” (patients 
classified as having mild dysphagia severity) versus “not mild” (patients classified as 
having moderate or severe dysphagia severity), which resulted in 266 observations for 
the “mild” group and 93 observations for the “not mild” group. For our final result, when 
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assessing the cost differences between patients stratified by two severity groups (mild 
versus not mild), we found that depression, moderate or severe dysphagia severity, and 
stroke severity all had significant effects on cost. When we controlled for dysphagia 
severity and stroke severity, the marginal cost difference for dysphagic patients with a 
diagnosis of depression was $10,745 higher than for those without depression. These 
finding may be more intuitive than our previous findings in that it may be more feasible 
for patients with both greater dysphagia severity and greater stroke severity, along with 
their respective comorbidities and complications, to incur higher mean total healthcare 
costs than patients with mild dysphagia. 
 
Related Research 
Although there are no other studies that have examined 90-day post-discharge costs in 
dysphagic patients with PSD, there are similar studies by which to make general 
comparisons. For example, in a recent systematic review by Marin et al. (2020), the 
authors examined healthcare costs associated with post-stroke dysphagia and related 
complications and found evidence that patients diagnosed with dysphagia after stroke 
incurred higher costs than patients not diagnosed with dysphagia after stroke. There 
were very few studies that assessed post-discharge cost; however, the authors found two 
that examined healthcare costs after discharge from the acute hospital. One study by 
Bonilha and colleagues (2014) examined the one-year cost associated with post-stroke 
dysphagia, while the other study by Gomes and colleagues (2016) examined the 
predictive ability of the Malnutrition Universal Screening Tool (MUST) on stroke 
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outcomes, including risk of malnutrition and hospitalization costs. Gomes et al. (2016) 
prospectively recruited patients over the age of 18 with a diagnosis of ischemic or 
hemorrhagic stroke from two hyperacute stroke units in London and assessed all 
hospitalization costs during a six-month period after stroke (Gomes et al., 2016). Gomes 
et al. (2020) found an increase in costs from patients with low risk of malnutrition (via 
MUST) to patients with high risk of malnutrition, from £4,920 (approximately $8,780 
[USD, 2019]) to £8,720 (approximately $15,560 [USD, 2019]), respectively (Marin et al., 
2020, p. 11). Furthermore, the researchers reported 77% higher median costs for 
patients with high risk of malnutrition compared to those with low risk of malnutrition 
(Gomes et al., 2020). Gomes et al. (2020) did not directly link malnutrition risk to post-
stroke dysphagia as they did not formally assess dysphagia; however, results of 
“inadequate swallow” from a bedside nursing swallow screen were reported. The 
researchers found that patients with high risk of malnutrition were more likely to have 
“inadequate swallow” (Gomes et al., 2020), indicating possible dysphagia. Thus, even 
though higher malnutrition costs were not directly attributed to dysphagia, it is feasible 
that because malnutrition in patients after stroke is a common (and serious) complication 
of post-stroke dysphagia (Foley et al., 2009), higher healthcare costs could have 
potentially been a consequence of dysphagia-related malnutrition. Although we cannot 
directly compare our results to Gomes et al.’s (2020) findings, there appears to be a 
similar inclination in directionality of the association between post stroke dysphagia-




With regard to depression, stroke survivors with PSD generally have greater healthcare 
utilization (Jia et al., 2006); therefore, higher healthcare costs would be expected in this 
patient population. Again, to our knowledge, there are no other studies that examined 
90-day post-discharge costs in dysphagic patients with PSD; however, we can make 
general comparisons to similar studies. Husaini, et al. (2013) conducted a study 
retrospectively examining the effect of depression on hospitalization costs in stroke 
patients using data from the 2008 Tennessee Hospital Discharge Data System and found 
that depressive symptoms were associated with increased healthcare costs. The 
researchers reported that stroke patients with depression had approximately 63% higher 
mean hospitalization costs compared to the stroke only cohort ($77,864 versus $47,790, 
respectively; Husaini, et al., 2013). In another study, Chinthammit et al. (2017) 
retrospectively examined the impact of co-occurring conditions on total and component 
healthcare expenditures (e.g., inpatient, outpatient, emergency room (ER), prescription 
drugs, home health, and other) in stroke survivors versus a non-stroke matched control 
group using 2002-2012 Medical Expenditure Panel Survey (MEPS) data. The researchers 
found that total expenditures were significantly higher in stroke patients with certain 
concurrent conditions, such as depression, compared to matched controls ($23,122 
versus $19,705, respectively; Chinthammit et al., 2017). They also found that stroke 
patients with depression had significantly greater inpatient expenditures compared to 




Although differences in methodologies, patient populations (i.e., stroke type), study 
timeframes, and primary outcomes among the studies discussed do not allow for direct 
comparisons with our study results, there is a clear trend in higher healthcare costs 
associated with the two separate stroke sequelae, dysphagia and depression, 
respectively. Thus, it is reasonable to suggest that post-stroke dysphagic patients with 
PSD would also incur higher healthcare costs than post-stroke dysphagic patients without 
PSD, which is what we found in this study. The increase in healthcare costs is likely due to 
increased healthcare utilization as a result of the higher healthcare utilization by patients 
diagnosed with depression after stroke, which have previously not been examined. This 
study is a starting point towards understanding the healthcare costs associated with both 
post-stroke dysphagia and PSD. Its value is not only in establishing these costs but also in 
highlighting the need for earlier detection and intervention for patients with post-stroke 
dysphagia and PSD with the goals of providing appropriate care for patients and 
potentially easing the economic burden of these co-occurring conditions. 
 
Section 3: Aim 3 Limitations 
We had the same limitations for Aim 3 as we had for Aims 1 and 2, with some additions. 
First, the administrative files from which we extracted our claims data did not provide 
itemized cost; therefore, we did not have access to medication cost and could not assess 
the cost of pharmacological treatment for PSD. Second, the small sample sizes in our 
moderate and severe dysphagia severity subgroups could have been prohibitive in 




This research has contributed to the existing dysphagia body of knowledge by examining 
a rarely studied population, post-stroke dysphagic patients with depression, and 
revealing new insights into the relationship between post-stroke dysphagia and PSD. 
Furthermore, this study has addressed a gap in the literature by providing a novel 
method for dysphagia severity classification in stroke patients for use with 
administrative-level data, which previously did not exist. 
 
 Results of this study demonstrated evidence of an association between PSD and post-
stroke dysphagia. That is, patients with post-stroke dysphagia had significantly greater 
odds and hazard of being diagnosed with PSD within 90 days after discharge, and patients 
diagnosed with both dysphagia and PSD incurred higher post-discharge healthcare costs. 
In the application of our novel dysphagia severity index (the ADDSS), we found that 
patients with less dysphagia severity were diagnosed with PSD sooner after discharge 
than patients with greater dysphagia severity, which highlighted the need for early and 
recurrent depression screening for post-stroke patients, particularly, with greater 
dysphagia severity. We also found that (counterintuitively) greater dysphagia severity did 
not increase the odds of PSD diagnosis after discharge, which we proposed could be due 





relation to PSD, regardless of severity. Another reason could be due to the well-known 
problems of underdiagnosis and undercoding of dysphagia and depression, which could 
have been barriers in detecting the true proportions of patients with diagnoses of post-
stroke dysphagia and PSD, especially in patients with more severe dysphagia, in which 
depressive symptoms can be more challenging to detect and also due to healthcare 
providers’ focus on life-sustaining functions over psychological manifestations in the 
acute post-stroke setting. Furthermore, we discovered an interesting and unexpected 
finding that (in discordance with some literature) dysphagia severity categories were not 
the same as stroke severity categories, which has implications for administrative-level 
post-stroke dysphagia related research and the methodologies used to classify dysphagia 
severity. These findings also highlight the importance of not using stroke severity as a 
proxy for dysphagia severity in stroke research. 
 
The foundational knowledge gained from this study is a starting point to understanding 
the influence of PSD on post-stroke dysphagia in pursuit of improved identification of and 
earlier intervention for dysphagic patients with depression after stroke. Furthermore, the 
glaring problems of underdetection and underdiagnosis of dysphagia and PSD discussed 
in this study underscore the importance of active and continued monitoring for 
depressive symptoms in this patient population and the need for implementation of 
adjunctive screening for depressive symptoms along with post-stroke dysphagia 
screening and/or assessment. Additionally, the potential utility for use of the ADDSS not 
only in administrative-level research but also in conjunction with additional data sources, 
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such as randomized clinical trials or prospective cohort studies, guides the next steps in 
this line of research, which is to validate the ADDSS. Finally, despite the prevalence of this 
patient population, the cost of care in patients with post-stroke dysphagia and 
depression has not been examined prior to this study; therefore, future studies to 
quantify healthcare costs of acute and chronic post-stroke dysphagic patients with 
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Appendix 1: ICD-10-CM Codes 




J13, J14, J15.0, J15.1, 
J15.20, J15.211, 
J15.212, J15.29, J15.3, 
J15.4, J15.5, J15.6, 
J15.8, J18.9, J69.0 
Due to: Streptococcus pneumoniae; Hemophilus 
influenzae; Klebsiella pneumoniae; 
Pseudomonas; Staphylococcus, unspecified; 
Methicillin susceptible Staphylococcus aureus; 
Methicillin resistant Staphylococcus aureus; 
Other staphylococcus; Streptococcus, group B; 
Other streptococci; Escherichia coli; Other Gram-
negative bacteria; Other specified bacteria; 
Unspecified organism; Pneumonitis due to 
inhalation of food and vomit 
 




Food in pharynx causing asphyxiation; Food in 
larynx causing asphyxiation; Food in bronchus 
causing asphyxiation; Food in other parts of 
respiratory tract causing asphyxiation; Food in 
respiratory tract, part unspecified, causing 





I69.01, I69.11, I69.21, 
I69.31, I69.81, I69.91, 
G31.84, G31.9, R41.4, 
R41.81, R41.82, 




Cognitive deficits following: Nontraumatic 
subarachnoid hemorrhage; Nontraumatic 
intracerebral hemorrhage; Other nontraumatic 
intracranial hemorrhage; Cerebral infarction; 
Other cerebrovascular disease; Unspecified 
cerebrovascular disease; Mild cognitive 
impairment; Degenerative disease of nervous 
system, unspecified; Neurologic neglect 
syndrome; Age-related cognitive decline; Altered 
mental status, unspecified; Unspecified 
symptoms and signs involving cognitive functions 
and awareness; Intracranial injury; Vascular 
dementia; Dementia in other diseases classified 
elsewhere; Unspecified dementia; Other 






Depression F32.x, F33.x Major depressive disorder, single episode; Major 






Aphagia or Dysphagia 




Dysphagia following nontraumatic subarachnoid 
hemorrhage; Dysphagia following 
nontraumatic intracerebral hemorrhage; 
Dysphagia following other nontraumatic 
intracranial hemorrhage; Dysphagia 
following cerebral infarction or stroke NOS; 
Dysphagia following cerebrovascular disease, 
specified NEC; Dysphagia following 
cerebrovascular disease, unspecified 
 
















Complete loss of teeth; Complete loss of teeth, 
unspecified cause; Complete loss of teeth, 
unspecified cause, class I; Complete loss of teeth, 
unspecified cause, class II; Complete loss of 
teeth, unspecified cause, class III; Complete loss 
of teeth, unspecified cause, class IV; Complete 
loss of teeth UC, unspecified class; Complete loss 
of teeth due to trauma; Complete loss of teeth 
due to trauma, class I; Complete loss of teeth due 
to trauma, class II; Complete loss of teeth due to 
trauma, class III; Complete loss of teeth due to 
trauma, class IV; Complete loss of teeth due to 
trauma, unspecified class; Complete loss of teeth 
due to periodontal disease; Complete loss of 
teeth due to periodontal disease, class I; 
Complete loss of teeth due to periodontal 
disease, class II; Complete loss of teeth due to 
periodontal disease, class III; Complete loss of 
teeth due to periodontal disease, class IV; 
Complete loss of teeth due to periodontal 
disease, unspecified class; Complete loss of teeth 
due to caries; Complete loss of teeth due to 
caries, class I; Complete loss of teeth due to 
caries, class II; Complete loss of teeth due to 
caries, class III; Complete loss of teeth due to 
caries, class IV; Complete loss of teeth due to 
caries, unspecified class; Complete loss of teeth 
due to other specified cause; Complete loss of 
teeth due to other specified cause, class I; 
Complete loss of teeth due to other specified 
cause, class II; Complete loss of teeth due to 
other specified cause, class III; Complete loss of 
teeth due to other specified cause, class IV; 
Complete loss of teeth due to other specified 









K21.00, K21.01, K22.0, 
K22.5           
Other esophagitis, specified NEC without 
bleeding; Other esophagitis with 
bleeding; Esophagitis, unspecified without 
bleeding; Esophagitis, unspecified with bleeding; 
Gastro-esophageal reflux disease with 
esophagitis without bleeding; Gastro-esophageal 
reflux disease with esophagitis with 
bleeding; Achalasia of cardia; Diverticulum of 
esophagus, acquired  
 
Feeding problems R63.3, R63.4, R63.6, 
R63.8, Z93.1 
Problem with feeding; Abnormal weight loss 
(cause unknown); Underweight; Other symptoms 
and signs concerning food and fluid intake; 
Presence of gastrostomy  
 
Malnutrition E44.1, E44.0, E43.0, 
E46  
Mild protein-calorie malnutrition; Moderate 
protein-calorie malnutrition; Unspecified severe 
protein-calorie malnutrition; Unspecified protein-
calorie malnutrition 
 
Paralysis of vocal 
cords and larynx 
J38.0, J38.00, J38.01, 
J38.02 
Paralysis of vocal cords and larynx; Paralysis of 
vocal cords and larynx, unspecified; Paralysis of 
vocal cords and larynx, unilateral; Paralysis of 




J80, J96, R06.0, 
R06.00, R06.03   
Acute respiratory distress syndrome; Respiratory 
failure NEC; Dyspnea; Dyspnea, unspecified, 








Stroke (ischemic) I63.x Cerebral infarction 
 








Appendix 2: ICD-10-PCS Codes 































Insertion of device in: Duodenum, open 
approach; Duodenum, percutaneous approach; 
Duodenum, percutaneous endoscopic approach; 
Duodenum, via natural or artificial opening; 
Duodenum, via natural or artificial opening 
endoscopic; Esophagus, open approach; 
Esophagus, percutaneous approach; Esophagus, 
percutaneous endoscopic approach; Esophagus, 
via natural or artificial opening; Esophagus, via 
natural or artificial opening endoscopic; Ileum, 
open approach; Ileum, percutaneous approach; 
Ileum, percutaneous endoscopic approach; Ileum, 
via natural or artificial opening; Ileum, via natural 
or artificial opening endoscopic; Small intestine, 
open approach; Small intestine, percutaneous 
approach; Small intestine, percutaneous 
endoscopic approach; Small intestine, via natural 
or artificial opening; Small intestine, via natural or 
artificial opening endoscopic; Jejunum, open 
approach; Jejunum, percutaneous approach; 
Jejunum, percutaneous endoscopic approach 
(PEJ); Jejunum, via natural or artificial opening; 
Jejunum, via natural or artificial opening 
endoscopic; Stomach, open approach; Stomach, 
percutaneous approach; Stomach, percutaneous 
endoscopic approach (PEG); Stomach, via natural 
or artificial opening; Stomach, via natural or 








0DP63UZ, 0DP64UZ  
 
Removal of device from: Esophagus, open 
approach; Esophagus, percutaneous approach; 
Esophagus, percutaneous endoscopic approach; 
Lower intestinal tract, open approach; Lower 
intestinal tract, percutaneous approach; Lower 
intestinal tract, percutaneous endoscopic 
approach; Upper intestinal tract, open approach; 
Upper intestinal tract, percutaneous approach; 
Upper intestinal tract, percutaneous endoscopic 
approach; Stomach, 
open approach; Stomach, percutaneous 








Insertion of endotracheal airway into trachea via 








Bedside swallowing and oral function assessment; 
Instrumental swallowing and oral function 
assessment using swallowing equipment; 
Instrumental swallowing and oral function 
assessment using aerodynamic function 
equipment; Instrumental swallowing and oral 








Swallowing dysfunction treatment; Swallowing 
dysfunction treatment using 
augmentative/alternative communication 
equipment; Swallowing dysfunction treatment 
using aerodynamic function 
equipment; Swallowing dysfunction treatment 
using speech prosthesis; Swallowing dysfunction 






Bypass trachea to cutaneous with tracheostomy 
device, open approach; Bypass trachea to 
cutaneous with tracheostomy device, 
percutaneous approach; Bypass trachea to 
cutaneous with tracheostomy device, 








Removal of tracheostomy device from trachea, 
open approach; Removal of tracheostomy device 
from trachea, percutaneous approach; Removal 
of tracheostomy device from trachea, external 
approach; Removal of tracheostomy device from 
trachea, percutaneous endoscopic approach; 
Removal of tracheostomy device from trachea, 
via natural or artificial opening; Removal of 
tracheostomy device from trachea, via natural or 
artificial opening  
 
Ventilator use 5A1935Z, 5A1945Z, 
5A19557 
Respiratory ventilation, <24 consecutive hours; 
Respiratory ventilation, 24-96 consecutive hours; 






Appendix 3: Level I CPT and Level II HCPCS Codes 








Evaluation of oral and pharyngeal swallowing 
function; Swallowing function, with 
cineradiography/videoradiography (modified 
barium swallow study); Motion fluoroscopic 
evaluation of swallowing function by cine or video 
recording (modified barium swallow study); 
Flexible fiberoptic endoscopic evaluation of 
swallowing by cine or video recording (FEES); 
Flexible fiberoptic endoscopic evaluation of 
swallowing and laryngeal sensory testing by cine or 




92526, 92508 Treatment of swallowing dysfunction and/or oral 
function for feeding; Group dysphagia therapy  
 













Nasogastric tubing with stylet; Nasogastric tubing 
without stylet; Stomach tube levin; 
Gastrostomy/Jejunostomy tube, standard; 




Food thickener B4100b  
 
Food thickener, administered orally 
 
Speaking valve L8501 Tracheostomy speaking valve 
 
Suction A4628, A4605, 
A4624 
 
Oropharyngeal suction catheter; Tracheal suction 
catheter, closed system; Tracheal suction catheter, 





E0465 Home ventilator, any type, used with invasive 
interface, (e.g., tracheostomy tube)  
 
Footnote: a74230 (radiology) + 92611 (speech-language pathology) should be billed 
together, b=non-billable code 
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J13, J14, J15.0, J15.1, J15.20, J15.211, J15.212, J15.29, J15.3, J15.4, 
J15.5, J15.6, J15.8, J18.9, J69.0 
 
Aspiration of food T17.220, T17.320, T17.520, T17.820, T17.920, T17.420 
 
Cognitive impairment I69.01, I69.11, I69.21, I69.31, I69.81, I69.91, G31.84, G31.9, R41.4, 




Edentulous K08.1, K08.10, K08.101, K08.102, K08.103, K08.104, K08.109, 
K08.11, K08.111, K08.112, K08.113, K08.114, K08.119, K08.12, 
K08.121, K08.122, K08.123, K08.124, K08.129, K08.13, K08.131, 
K08.132, K08.133, K08.134, K08.139, K08.19, K08.191, K08.192, 









K20.80, K20.81, K20.90, K20.91, K21.00, K21.01, K22.0, K22.5    
        
Feeding device, insertion 
(placement) 
0DH90UZ, 0DH93UZ, 0DH94UZ, 0DH97UZ, 0DH98UZ, 0DH50UZ, 
0DH53UZ, 0DH54UZ, 0DH57UZ, 0DH58UZ, 0DHB0UZ, 0DHB3UZ, 
0DHB4UZ, 0DHB7UZ, 0DHB8UZ, 0DH80UZ, 0DH83UZ, 0DH84UZ, 
0DH87UZ, 0DH88UZ, 0DHA0UZ, 0DHA3UZ, 0DHA4UZ, 0DHA7UZ, 
0DHA8UZ, 0DH60UZ, 0DH63UZ, 0DH64UZ, 0DH67UZ, 0DH68UZ  
 
Feeding device, removal 0DP50UZ, 0DP53UZ, 0DP54UZ, 0DPD0UZ, 0DPD3UZ, 0DPD4UZ, 




R63.3, R63.4, R63.6, R63.8, Z93.1 









Paralysis of vocal cords 
and larynx 
 
J38.0, J38.00, J38.01, J38.02 
Respiratory problems 
 








F00ZHZZ, F00ZJWZ, F00ZJTZ, F00ZJYZ, 92610a, 74230a, 92611a, 















0BP10FZ, 0BP13FZ, 0BP1XFZ, 0BP14FZ, 0BP17FZ, 0BP18FZ 
Ventilator use 
 
5A1935Z, 5A1945Z, 5A19557, E0465b 











Appendix 5: Healthcare costs by dysphagia severity 





































Costb Incurred      



































Footnote: N=population size, n=sample size, SD=standard deviation, IP=inpatient costs 
after discharge, OP=outpatient costs, HH=home health costs, SNf=skilled nursing facility 
costs, Carrier=carrier costs  
aMild dysphagia severity with moderate stroke; Moderate dysphagia severity with 
moderate/severe stroke; Severe dysphagia severity with moderate stroke. 









Appendix 6: Healthcare costs by discharge location 













































































Footnote: N=population size, n=sample size, SD=standard deviation, IPR=inpatient 
rehabilitation, SNF=skilled nursing facility, Trans=transferred to another facility, Total 
90=total healthcare related costs during 90-day period after discharge, IP=inpatient costs 
after discharge, OP=outpatient costs, HH=home health costs, SNf= skilled nursing facility 
costs, Carrier=carrier costs.  
aCost in United States dollars (USD)  
